10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2018

or

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-36316

AgroFresh Solutions, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware	46-4007249
(State or other jurisdiction of incorporation)	(IRS Employer Identification Number)

One Washington Square

510-530 Walnut Street, Suite 1350

Philadelphia, PA 19106

(Address of principal executive offices)

(267) 317-9139

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x Yes ¨ No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). x Yes ¨ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ¨	Accelerated filer x	Non-accelerated filer ¨	Smaller reporting company ¨	Emerging growth company x
		(Do not check if a smaller reporting company)

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Act). ¨ Yes x No

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

The number of shares of common stock outstanding as of May 3, 2018 was 50,430,366.

TABLE OF CONTENTS

			Page
PART I - FINANCIAL INFORMATION
	Item 1. Condensed Consolidated Financial Statements (Unaudited)
		Condensed Consolidated Balance Sheets	3
		Condensed Consolidated Statements of Operations	4
		Condensed Consolidated Statements of Comprehensive Loss	5
		Condensed Consolidated Statement of Stockholders' Equity	6
		Condensed Consolidated Statement of Cash Flows	7
		Notes to Condensed Consolidated Financial Statements	8
	Item 2. Management's Discussion and Analysis of Financial Condition and Result of Operations		24
	Item 3. Quantitative and Qualitative Disclosures About Market Risk		31
	Item 4. Controls and Procedures		31
PART II - OTHER INFORMATION			32
	Item 1. Legal Proceedings		32
	Item 1A. Risk Factors		32
	Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		33
	Item 3. Defaults Upon Senior Securities		33
	Item 4. Mine Safety and Disclosures		33
	Item 5. Other Information		33
	Item 6. Exhibits		34
SIGNATURES			35

2

PART I - FINANCIAL INFORMATION

AgroFresh Solutions, Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and per share data)

	March 31, 2018			December 31, 2017
ASSETS
Current Assets:
Cash and cash equivalents	$	56,962		$	64,533
Accounts receivable, net of allowance for doubtful accounts of $1,463 and $1,550, respectively	65,766			71,509
Inventories	20,612			24,109
Other current assets	21,840			18,684
Total current assets	165,180			178,835
Property and equipment, net	13,737			12,200
Goodwill	5,748			9,402
Intangible assets, net	746,977			757,882
Deferred income tax assets	6,606			8,198
Other assets	11,308			16,746
TOTAL ASSETS	$	949,556		$	983,263
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	7,337		$	15,014
Current portion of long-term debt	7,700			7,926
Income taxes payable	7,689			5,931
Accrued expenses and other current liabilities	43,391			65,809
Total current liabilities	66,117			94,680
Long-term debt	402,209			402,868
Other noncurrent liabilities	39,193			38,505
Deferred income tax liabilities	33,168			31,130
Total liabilities	540,687			567,183
Commitments and contingencies (see Note 17)
Stockholders’ equity:
Common stock, par value $0.0001; 400,000,000 shares authorized, 51,055,747 and 51,002,234 shares issued and 50,394,366 and 50,340,853 shares outstanding at March 31, 2018 and December 31, 2017, respectively	5			5
Preferred stock; par value $0.0001, 1 share authorized and outstanding at March 31, 2018 and December 31, 2017	—			—
Treasury stock; par value $0.0001, 661,381 shares at March 31, 2018 and December 31, 2017	(3,885		)	(3,885		)
Additional paid-in capital	533,524			533,015
Accumulated deficit	(121,696		)	(108,729		)
Accumulated other comprehensive loss	(7,613		)	(12,769		)
Total AgroFresh stockholders’ equity	400,335			407,637
Non-controlling Interest	8,534			8,443
Total stockholders' equity	408,869			416,080
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	949,556		$	983,263

 See accompanying notes to condensed consolidated financial statements.

3

AgroFresh Solutions, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except share and per share data)

	Three Months Ended March 31, 2018			Three Months Ended March 31, 2017
Net sales	$	38,351		$	32,730
Cost of sales (excluding amortization, shown separately below)	10,846			5,839
Gross profit	27,505			26,891
Research and development expenses	3,069			3,297
Selling, general, and administrative expenses	16,311			16,431
Amortization of intangibles	10,939			10,445
Change in fair value of contingent consideration	138			215
Operating loss	(2,952		)	(3,497		)
Other income	70			40
Gain on foreign currency exchange	1,931			3,103
Interest expense, net	(8,355		)	(10,293		)
Loss before income taxes	(9,306		)	(10,647		)
Provision for income taxes	3,570			1,382
Net loss including non-controlling interests	$	(12,876	)	$	(12,029	)
Less: Net income attributable to non-controlling interests	91			—
Net loss attributable to AgroFresh Solutions, Inc	$	(12,967	)	$	(12,029	)
Net loss per share:
Basic	$	(0.26	)	$	(0.24	)
Diluted	$	(0.26	)	$	(0.24	)
Weighted average shares outstanding:
Basic	49,741,593			49,661,469
Diluted	49,741,593			49,661,469

See accompanying notes to condensed consolidated financial statements.

4

AgroFresh Solutions, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Unaudited)

(In thousands)

	Three Months Ended March 31, 2018			Three Months Ended March 31, 2017
Net loss	$	(12,876	)	$	(12,029	)
Other comprehensive income (loss):
Unrealized gain on hedging activity, net of tax $594	2,106			—
Foreign currency translation adjustments	3,050			(1,870		)
Comprehensive loss	$	(7,720	)	$	(13,899	)

See accompanying notes to condensed consolidated financial statements.

5

AgroFresh Solutions, Inc.

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

(Unaudited)

(In thousands, except share and per share data)

	Preferred Stock			Common Stock			Treasury Stock			Additional Paid-in Capital		Accumulated Deficit			Accumulated Other Comprehensive Loss			Total Stockholders’ Equity
	Shares	Amount		Shares	Amount		Amount
Balance at December 31, 2016	1	$	—	50,698,587	$	5	$	(3,885	)	$	475,598	$	(132,200	)	$	(4,373	)	$	335,145
Stock-based compensation	—	—		—	—		—			216		—			—			216
Transfer of director compensation from liability to equity	—	—		—	—		—			40		—			—			40
Issuance of restricted stock	—	—		243,620	—		—			—		—			—			—
Comprehensive loss	—	—		—	—		—			—		(12,029		)	(1,870		)	(13,899		)
Balance at March 31, 2017	1	$	—	50,942,207	$	5	$	(3,885	)	$	475,854	$	(144,229	)	$	(6,243	)	$	321,502

	Preferred Stock			Common Stock			Treasury Stock			Additional Paid-in Capital		Accumulated Deficit			Accumulated Other Comprehensive Income (Loss)			Non-Controlling Interest		Total Stockholders’ Equity
	Shares	Amount		Shares	Amount		Amount
Balance at December 31, 2017	1	$	—	51,002,234	$	5	$	(3,885	)	$	533,015	$	(108,729	)	$	(12,769	)	$	8,443	$	416,080
Stock-based compensation	—	—		—	—		—			509		—			—			—		509
Issuance of stock, net of forfeitures	—	—		53,513	—		—			—		—			—			—		—
Comprehensive loss	—	—		—	—		—			—		(12,967		)	5,156			91		(7,720		)
Balance at March 31, 2018	1	$	—	51,055,747	$	5	$	(3,885	)	$	533,524	$	(121,696	)	$	(7,613	)	$	8,534	$	408,869

See accompanying notes to condensed consolidated financial statements.

6

AgroFresh Solutions, Inc.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(Unaudited)

(in thousands)	Three Months Ended March 31, 2018			Three Months Ended March 31, 2017
Cash flows from operating activities:
Net loss	$	(12,876	)	$	(12,029	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	11,273			10,978
Provision for bad debts	52			180
Stock-based compensation	609			216
Pension expense	347			49
Unrealized gain on derivative instrument	—			—
Amortization of deferred financing costs	601			579
Accretion of contingent consideration	—			3,704
Increase in fair value of contingent consideration	138			215
Deferred income taxes	3,630			232
Loss on sales of property	—			81
Other	—			43
Changes in operating assets and liabilities:
Accounts receivable	5,818			9,148
Inventories	3,497			(637		)
Prepaid expenses and other current assets	(430		)	407
Accounts payable	(7,853		)	(5,013		)
Accrued expenses and other liabilities	(9,426		)	(716		)
Income taxes payable	1,758			(9		)
Other assets and liabilities	6,279			1,408
Net cash provided by operating activities	3,417			8,836
Cash flows from investing activities:
Cash paid for property and equipment	(1,905		)	(1,014		)
Other investments	—			(350		)
Net cash used in investing activities	(1,905		)	(1,364		)
Cash flows from financing activities:
Payment of Dow liabilities settlement	(10,000		)	—
Repayment of long term debt	(1,407		)	(1,063		)
Net cash used in financing activities	(11,407		)	(1,063		)
Effect of exchange rate changes on cash and cash equivalents	2,324			1,137
Net (decrease) increase in cash and cash equivalents	(7,571		)	7,546
Cash and cash equivalents, beginning of period	$	64,533		77,312
Cash and cash equivalents, end of period	$	56,962		$	84,858
Supplemental disclosures of cash flow information:
Cash paid for:
Cash paid for interest	$	7,242		$	6,085
Cash paid for income taxes	$	156		$	679
Supplemental schedule of non-cash investing and financing activities:
Accrued purchases of property and equipment	$	—		$	578

See accompanying notes to condensed consolidated financial statements.

7

AgroFresh Solutions, Inc.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. Description of Business

AgroFresh Solutions, Inc. (the “Company”) is a global leader in delivering innovative food preservation and waste reduction solutions for fresh produce. The Company is empowering the food industry with Smarter Freshness^TM, a range of integrated solutions designed to help growers, packers and retailers improve produce freshness and quality while reducing waste. The Company’s solutions range from pre-harvest with Harvista^TM and LandSpring^TM to its marqueeSmartFresh^TM Quality System, which includes SmartFresh^TM, AdvanStore^TM and ActiMist^TM, working together to maintain the quality of stored produce. The Company has a controlling interest in Tecnidex Fruit Protection, S.A.U. (“Tecnidex”), a leading provider of post-harvest fungicides, waxes, coatings and biocides for the citrus market. Additionally, the Company’s initial retail solution, RipeLock^TM, optimizes banana ripening for the benefit of retailers and consumers. The Company has key products registered in over 45 countries, supports approximately 3,700 direct customers and services over 25,000 storage rooms globally.

The end markets that the Company serves are seasonal and are generally aligned with the seasonal growing patterns of the Company’s customers. For those customers growing, harvesting or storing apples, the Company’s primary market, the peak season in the southern hemisphere is the first and second quarters of each year, while the peak season in the northern hemisphere is the third and fourth quarters of each year. Within each half-year period (i.e., January through June for the southern hemisphere, and July through December for the northern hemisphere) the apple growing season has historically occurred during both quarters. A variety of factors, including weather, may affect the timing of the growing, harvesting and storing patterns of the Company’s customers and therefore shift the consumption of the Company’s services and products between the first and second quarters primarily in the southern hemisphere or between the third and fourth quarters primarily in the northern hemisphere.

The Company was originally incorporated as Boulevard Acquisition Corp. (“Boulevard”), a blank check company, in Delaware on October 24, 2013, and was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. On July 31, 2015, the Company completed a Business Combination (refer to Note 3) and changed its name to AgroFresh Solutions, Inc. Prior to consummation of the Business Combination, the Company’s efforts were limited to organizational activities, its initial public offering and related financings, and the search for suitable business acquisition transactions.

2. Basis of Presentation and Summary of Significant Accounting Policies

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and in accordance with the rules and regulations of the Securities and Exchange Commission. These financial statements include all adjustments that are necessary for a fair presentation of the Company's condensed consolidated results of operations, financial condition and cash flows for the periods shown, including normal, recurring accruals and other items. The condensed consolidated results of operations for the interim periods presented are not necessarily indicative of results for the full year.

Revenue Recognition

On January 1, 2018, the Company began to account for revenue in accordance with Accounting Standards Codification ("ASC") 606, which requires revenue recognized to represent the transfer of promised goods or services to customers at an amount that reflects the consideration which is expected to be received in exchange for those goods or services. The Company utilized the modified retrospective method of adoption to all contracts that were not completed as of January 1, 2018. Prior period results were not adjusted and continue to be reported under the accounting standards in effect for the prior period. The Company has not made any significant changes to judgments in applying ASC 606 during the three months ended March 31, 2018

Performance Obligations

The Company derives revenue from the sale of products created with proprietary technology to regulate the ripening of produce and through performing post application technical services for its customers. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account in ASC 606. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The majority of the Company’s contracts have multiple performance obligations primarily related to product application and post application services which the Company provides. For contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation using the best estimate of the standalone selling price of each distinct good or service in the contract. The method used to estimate standalone selling price is the expected cost plus a margin approach, under which the Company calculates the costs of satisfying a performance obligation and factors in an appropriate margin for that distinct good or service.

8

The transaction price is primarily fixed as prices are governed by the terms and conditions of the Company's contracts with customers; payment is typically made under standard terms. The Company has certain transactions that provide for variable consideration through rebate and customer loyalty programs. Depending on the program, the customer may elect to receive either a credit against its account or a cash payment. The Company recognizes an accrued provision for estimated rebates and customer loyalty program payouts at the time services are provided. The primary factors considered when estimating the provision for rebates and customer loyalty programs are the average historical experience of aggregate credits issued, the historical relationship of rebates as a percentage of total gross product sales, and the contract terms and conditions of the various rebate programs in effect at the time services are performed. The Company provides standard warranty provisions.

Performance obligations related to product application are typically satisfied at a point in time when the customer obtains control upon application. Performance obligations related to post application services are satisfied over time and revenue is recognized using the output method, as control of the service transfers to the customer over time during and after storage of the produce. The Company believes that this method provides a faithful depiction of the transfer of value over the term of the performance obligation because the level of effort in providing these services is consistent during the service period. Performance obligations related to Tecnidex sales-type leases are satisfied at the point in time that, equipment is installed at the customer site.

Disaggregation of Revenue

The Company disaggregates revenue from contracts with customers into geographic region, product and timing of transfer of goods and services. The Company determined that disaggregating revenue into these categories achieves the disclosure objective to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.

Revenues for the three months ended March 31, 2018 (in thousands)
Region	North America		EMEA		Latin America		Asia Pacific		Total Revenue
Product
1-MCP based	$	1,962	$	5,120	$	20,949	$	4,328	$	32,359
Fungicides, waxes, coatings, biocides	—		5,589		—		—		5,589
Other*	98		198		6		101		403
	$	2,060	$	10,907	$	20,955	$	4,429	$	38,351
Pattern of Revenue Recognition
Products transferred at a point in time	$	2,047	$	10,905	$	20,949	$	4,328	$	38,229
Services transferred over time	13		2		6		101		122
	$	2,060	$	10,907	$	20,955	$	4,429	$	38,351

*Other includes RipeLock, AdvanStore, technical services and sales type leases related to Tecnidex

Contract Assets and Liabilities

ASC 606 requires an entity to present a revenue contract as a contract asset when the entity performs its obligations under the contract by transferring goods or services to a customer before the customer pays consideration or before payment is due. ASC 606 also requires an entity to present a revenue contract as a contract liability in instances when a customer pays consideration, or an entity has a right to an amount of consideration that is unconditional (e.g. receivable), before the entity transfers a good or service to the customer. The following table presents changes in the Company’s contract assets and liabilities during the three months ended March 31, 2018:

Three months ended March 31, 2018	Balance at January 1, 2018		Additions		Deductions			Balance at March 31, 2018
(in thousands)
Contract assets:
Unbilled revenue	$	739	$	4,268	$	(739	)	$	4,268
Contract liabilities:
Deferred revenue	$	100	$	880	$	—		$	980

9

The Company recognizes contract assets in the form of unbilled revenue in instances where services are performed by the Company but not billed by period end. The Company recognizes contract liabilities in the form of deferred revenue in instances where a customer pays in advance for future services to be performed by the Company. The Company receives payments from its customers based on standard terms and conditions. No significant changes or impairment losses occurred to contract balances during the three months ended March 31, 2018. Amounts reclassified from unbilled revenue to accounts receivable for the three months ended March 31, 2018 were ($0.7 million). Amounts reclassified from deferred revenue to revenue were $0.0 million for the three months ended March 31, 2018.

Practical Expedients Elected

The Company has elected the following practical expedients in applying ASC 606 across all reportable segments:

Unsatisfied Performance Obligations. Because all of its performance obligations relate to contracts with a duration of less than one year, the Company has elected to apply the optional exemption provided in ASC 606 and therefore, is not required to disclose the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period.

Contract Costs. All incremental customer contract acquisition costs are expensed as they are incurred as the amortization period of the asset that the Company otherwise would have recognized is one year or less in duration.

Significant Financing Component.The Company does not adjust the promised amount of consideration for the effects of a significant financing component as the Company expects, at contract inception, that the period between when the entity transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.

Sales Tax Exclusion from the Transaction Price. The Company excludes from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from the customer.

Shipping and Handling Activities. The Company accounts for shipping and handling activities it performs after a customer obtains control of the good as activities to fulfill the promise to transfer the good.

Modified Retrospective Method. The Company adopted ASC 606 on January 1, 2018 utilizing the modified retrospective method, which meant the Company did not retrospectively adjust prior periods. The Company applied the modified retrospective method only to contracts that were not completed at January 1, 2018 and accounted for the aggregate effect of any contract modifications upon adoption. No cumulative adjustment to retained earnings was recorded upon adoption. The following table summarizes the amounts by which the consolidated financial statements are affected in the current reporting period by ASC 606 as compared with the guidance that was in effect before the change.

(in thousands)	As reported			ASC 606 Adjustments			Balances without adoption of ASC 606
Consolidated Balance Sheet
Liabilities
Accrued expenses and other current liabilities	$	43,391		$	(782	)	$	42,609
Equity
Accumulated deficit	$	(121,696	)	$	782		$	(120,914	)

(in thousands)	As reported			ASC 606 Adjustments		Balances without adoption of ASC 606
Consolidated Statements of Operations
Revenue
Net sales	$	38,351		$	782	$	39,133
Net loss attributable to AgroFresh Solutions, Inc	(12,967		)	$	610	$	(12,357	)

For additional information, these condensed consolidated financial statements should be read in conjunction with the consolidated and combined financial statements and notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2017.

10

Recently Issued Accounting Standards and Pronouncements

In August 2017, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2017-12 Targeted Improvements to Accounting for Hedging Activities. This update makes more financial and nonfinancial hedging strategies eligible for hedge accounting. It also amends the presentation and disclosure requirements and changes how companies assess effectiveness. This update will be effective for the Company for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted upon its issuance. The Company is currently assessing the impact of the future adoption of this standard on its financial statements.

In May 2017, the FASB issued ASU 2017-09, Compensation-Stock Compensation (Topic 718) Scope of Modification Accounting. ASU 2017-09 addresses the changes to the terms and conditions of share-based awards. ASU 2017-09 is effective for periods beginning after December 15, 2017 and interim periods therein on a modified retrospective basis. The Company adopted the new ASU as of January 1, 2018, and it did not have a material impact on the financial statements.

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other, which simplifies the test for goodwill impairment. The guidance is effective for the Company beginning in the first quarter of fiscal year 2020. Early adoption is permitted for interim or annual goodwill impairments tests after January 1, 2017. This standard will impact future financial statements when adopted.

In February 2016, the FASB issued ASU 2016-02, Leases. The main objective of this update is to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the impact ASU 2016-02 may have on its financial statements.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, which has been updated through several revisions and clarifications since its original issuance. The core principle of the new standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in accordance with the transfer of control over those goods and services. The new standard also requires additional disclosures intended to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue, and the related cash flows. The standard is effective for interim and annual reporting periods beginning after December 15, 2017. The Company adopted the new standard as of January 1, 2018, using the modified retrospective approach to all contracts that were not completed as of January 1, 2018. Prior period results were not adjusted and continue to be reported under the accounting standards in effect for the prior period. See the Revenue Recognition subsection above in this Note 2 for further details on the impact to the Company’s financial statements upon adoption and practical expedients elected.

11

3. Business Combinations

Business Combination with Dow

On July 31, 2015 (the "Closing Date"), the Company consummated a business combination (the “Business Combination”) pursuant to the Stock Purchase Agreement, dated April 30, 2015 (the “Purchase Agreement”), by and between the Company and The Dow Chemical Company ("Dow") providing for the acquisition by the Company of the AgroFresh Business from Dow, resulting in AgroFresh Inc. becoming a wholly-owned, indirect subsidiary of the Company. Pursuant to the Purchase Agreement, the Company paid the following consideration to Rohm and Haas Company (“R&H”), a subsidiary of Dow: (i) 17.5 million shares of common stock (the “Stock Consideration”) and (ii) $635 million in cash (the “Cash Consideration”).

On April 4, 2017, the Company entered into an agreement (the “Amendment Agreement”) with Dow, R&H, Boulevard Acquisition Sponsor, LLC (the “Sponsor”), AgroFresh Inc., Avenue Capital Management II, L.P. (“Avenue”) and, solely as to certain sections of the Amendment Agreement, Joel Citron, Darren Thompson and Robert J. Campbell (collectively, the “Founding Holders”), Marc Lasry and Stephen Trevor. Pursuant to the Amendment Agreement and certain related agreements entered into on the same date (as described below), among other things, the Company and Dow agreed to modify certain obligations of the Company pursuant to (i) the Purchase Agreement, (ii) the Tax Receivables Agreement, dated July 31, 2015 (the “Tax Receivables Agreement”), among the Company, Dow, R&H and AgroFresh Inc., and (iii) the Warrant Purchase Agreement, dated July 31, 2015 (the “Warrant Purchase Agreement”), among the Company, Dow, R&H and the Sponsor. Mr. Campbell is a member of the Company's board of directors, each of Mr. Lasry and Mr. Trevor was a member of the Company’s board of directors at the time the Amendment Agreement was entered into, Dow is a significant stockholder of the Company and the Sponsor was a significant stockholder of the Company at the time the Amendment Agreement was entered into.

Amendment Agreement

Pursuant to the Amendment Agreement, the Company agreed to pay Dow the aggregate amount of $20.0 million, of which $10.0 million was paid on April 4, 2017 and the remaining $10.0 million was paid on January 31, 2018, in full satisfaction of the Company’s obligations with respect to (i) the working capital adjustment under the Purchase Agreement, (ii) certain transfer and value added tax reimbursement obligations under the Purchase Agreement, and (iii) the amount payable to Dow pursuant to the Tax Receivables Agreement on account of the 2015 tax year. During the three the months ended March 31, 2018 these liabilities were extinguished.

First Amendment to Tax Receivables Agreement

The Company, Dow, R&H and AgroFresh Inc. entered into a First Amendment to the Tax Receivables Agreement (the “TRA Amendment”). The TRA Amendment reduces, from 85% to 50%, the percentage that the Company is required to pay to Dow pursuant to the Tax Receivables Agreement of the annual tax savings, if any, in U.S. federal, state and local income tax or franchise tax that the Company actually realizes as a result of the increase in tax basis of the AgroFresh assets resulting from a Section 338(h)(10) election that the Company and Dow made in connection with the Business Combination.

Stock Buyback Agreement

The Company and Dow entered into a letter agreement (the “Stock Buyback Agreement”), pursuant to which Dow agreed to use its reasonable best efforts to purchase up to 5,070,358 shares of the Company’s common stock in the open market (representing approximately 10% of the total number of shares of the Company’s common stock then outstanding), over a period of up to 18 months.

Termination of Warrant Purchase Agreement

The Company, Dow, R&H and the Sponsor entered into a letter agreement, pursuant to which the Warrant Purchase Agreement was terminated effective immediately.

As a result of the Amendment Agreement, the TRA Amendment and the termination of the Warrant Purchase Agreement, the Company recorded a reduction of liabilities of $95.1 million net of deferred income taxes of $40.0 million. The net impact of $55.1 million has been recorded to additional paid-in capital as the agreements were with related parties and the transaction has been treated as a capital transaction.

Acquisition of Tecnidex

On November 7, 2017, the Company entered into a definitive agreement to acquire a controlling-interest in Tecnidex Fruit Protection, S.A.U. ("Tecnidex"). The transaction was closed on December 1, 2017. Tecnidex, a privately-held international company, is a leading provider of post-harvest fungicides, waxes, coatings, and biocides for the citrus market, with clients in 18 countries. For over 35 years,

12

Tecnidex has been helping fruit and vegetable producers offer clean, safe and high-quality products to their regional clients. The acquisition was accounted for as a purchase in accordance with ASC 805, Business Combination.

At the effective date of the acquisition, the Company agreed to pay holders of Tecnidex estimated $25.0 million in cash for 75% of the outstanding capital stock, of which $20.0 million was paid on December 1, 2017. In the second quarter of 2018 the price is expected to be finalized and paid based on working capital, net debt and other adjustments.

In accordance with the acquisition method of accounting, the Company is allocating the purchase price to the estimated fair values of the identifiable assets acquired and liabilities assumed, with any excess allocated to goodwill. The allocation of the purchase price accounting is preliminary as the Company is still in the process of valuing the assets acquired and liabilities assumed; therefore the allocation of the acquisition consideration is subject to change.

The preliminary assessment of fair value of the contingent consideration payments on the acquisition date was approximately $0.7 million and was estimated by applying a probability-based income approach utilizing an appropriate discount rate. This estimation was based on significant inputs that are not observable in the market, referred to as Level 3 inputs. During the three months ended March 31, 2018 there was an adjustment made to consideration payable to holders of Tecnidex which resulted in a measurement period adjustment of $3.7 million to the purchase price allocation.

4. Related Party Transactions

The Company is a party to ongoing agreements with Dow, a related party, including, but not limited to, operating-related agreements for certain transition services and seconded employees. In addition, during the three months ended March 31, 2018, the Company paid $0.7 million to Dow in order to terminate the provision of IT services provided by Dow.

The Company incurred expenses for such services for the three months ended March 31, 2018 and March 31, 2017 as follows:

(amounts in thousands)	Three Months Ended March 31, 2018		Three Months Ended March 31, 2017
Amortization of prepayment related to set-up of transition services	$	—	$	207
Ongoing costs of transition services agreement	84		743
Rent expense	—		248
Other expenses	295		95
Total incurred expenses	$	379	$	1,293

As of March 31, 2018 and March 31, 2017, the Company had an outstanding payable to Dow of $0.0 million and $0.3 million, respectively.

Refer to Note 3 regarding the contingent consideration owed to Dow as part of the Business Combination.

In addition, during 2016, the Company made a minority investment in RipeLocker, LLC ("RipeLocker"), a company led by George Lobisser, a director of AgroFresh. On November 29, 2016, the Company entered into a Mutual Services Agreement (the “Services Agreement”) with George Lobisser and RipeLocker. Pursuant to the Services Agreement, (i) the Company agreed to provide RipeLocker with technical support, in the form of access to the Company’s research and development personnel for a specified number of hours for purposes of providing advice and input relating to RipeLocker’s products and services, and (ii) Mr. Lobisser agreed to provide consulting services to the Company as may be reasonably requested by the Company from time to time. The Services Agreement provided for Mr. Lobisser to receive a consulting fee of $5,000 per full day for time spent performing consulting services under the Services Agreement (pro-rated for any partial day), plus reimbursement for out-of-pocket expenses, provided that for each hour of technical support provided by the Company to RipeLocker, Mr. Lobisser agreed to provide one-half hour of consulting services for no consideration. In February 2017, the Company and Mr. Lobisser agreed to substantially curtail any mutual consulting services to be provided under the Services Agreement, and that any further services would be provided at no charge. For the three months ended March 31, 2018, there were no material amounts paid and as of March 31, 2018, there were no material amounts owed to RipeLocker or Mr. Lobisser for consulting services.

13

5. Inventories

Inventories at March 31, 2018 and December 31, 2017 consisted of the following:

(in thousands)	March 31, 2018		December 31, 2017
Raw material	$	1,967	$	2,148
Work-in-process	3,456		6,585
Finished goods	14,476		14,647
Supplies	713		729
Total inventories	$	20,612	$	24,109

6. Other Current Assets

The Company's other current assets at March 31, 2018 and December 31, 2017 consisted of the following:

(in thousands)	March 31, 2018		December 31, 2017
VAT receivable	$	14,454	$	14,088
Prepaid income tax asset	2,289		2,314
Other	5,097		2,282
Total other current assets	$	21,840	$	18,684

7. Property and Equipment

Property and equipment at March 31, 2018 and December 31, 2017 consisted of the following:

(in thousands, except for useful life data)	Useful life (years)	March 31, 2018			December 31, 2017
Leasehold improvements	7-20	$	3,015		$	2,976
Machinery & equipment	1-12	7,799			7,853
Furniture	1-12	1,707			1,698
Construction in progress		3,987			2,075
		16,508			14,602
Less: accumulated depreciation		(2,771		)	(2,402		)
Total property and equipment, net		$	13,737		$	12,200

Depreciation expense for the three months ended March 31, 2018 and March 31, 2017 was $0.4 million and $0.3 million, respectively. Depreciation expense is recorded in cost of sales, selling, general and administrative expense and research and development expense in the condensed consolidated statements of operations.

14

8. Goodwill and Intangible Assets

Changes in the carrying amount of goodwill for the three months ended March 31, 2018 are as follows:

(in thousands)	Goodwill
Balance as of December 31, 2017	$	9,402
Measurement period adjustment	(3,654		)
Balance as of March 31, 2018	$	5,748

See note 3 for a description of the measurement period adjustment.

The Company’s intangible assets at March 31, 2018 and December 31, 2017 consisted of the following:

	March 31, 2018							December 31, 2017
(in thousands)	Gross Carrying Amount		Accumulated Amortization			Net		Gross Carrying Amount		Accumulated Amortization			Net
Other intangible assets:
Developed technology	$	759,374	$	(105,089	)	$	654,285	$	759,374	$	(94,886	)	$	664,488
In-process research and development	39,000		(3,431		)	35,569		39,000		(2,889		)	36,111
Trade name	29,816		—			29,816		29,816		—			29,816
Service provider network	2,000		—			2,000		2,000		—			2,000
Customer relationships	20,306		(889		)	19,417		20,306		(806		)	19,500
Software	1,274		(477		)	797		1,274		(404		)	870
Software not yet placed in service	5,022		—			5,022		5,022					5,022
Other	100		(29		)	71		100		(25		)	75
Total intangible assets	$	856,892	$	(109,915	)	$	746,977	$	856,892	$	(99,010	)	$	757,882

At March 31, 2018, the weighted-average amortization period remaining for the finite-lived intangible assets was 17.1 years. At March 31, 2018, the weighted-average amortization periods remaining for developed technology, customer relationships, in-process R&D, software and other was 17.0, 21.3, 16.5, 2.6, and 4.3 years, respectively.

Estimated annual amortization expense for finite-lived intangible assets, excluding amounts in Work in Progress, subsequent to March 31, 2018 is as follows:

(in thousands)	Amount
2018 (remaining)	$	32,753
2019	43,970
2020	43,951
2021	43,814
2022	43,691
Thereafter	501,960
Total	$	710,139

15

9. Accrued and Other Current Liabilities

The Company’s accrued and other current liabilities at March 31, 2018 and December 31, 2017 consisted of the following:

(in thousands)	March 31, 2018		December 31, 2017
Tax amortization benefit contingency	$	11,820	$	11,820
Additional consideration due seller	831		693
Dow settlement liability	—		10,000
Accrued compensation and benefits	7,252		8,932
Accrued rebates payable	5,045		5,027
Insurance premium financing payable	321		639
Severance	395		113
Deferred revenue	980		100
Other notes payable	1,401		5,056
Accrued taxes	8,710		7,848
Accrued interest	6,527		6,321
Other	109		9,260
Total accrued and other current liabilities	$	43,391	$	65,809

10. Debt

The Company’s debt, net of unamortized discounts and deferred financing fees, at March 31, 2018 and December 31, 2017 consisted of the following:

(in thousands)	March 31, 2018		December 31, 2017
Total Term Loan outstanding	$	406,568	$	407,109
Tecnidex loan outstanding	3,341		3,685
Less: Amounts due within one year	7,700		7,926
Total long-term debt due after one year	$	402,209	$	402,868

At March 31, 2018, the Company evaluated the amount recorded under the Term Loan (defined below) and determined that the fair value was approximately $417.5 million. The fair value of the debt is based on quoted inactive market prices and is therefore classified as Level 2 within the valuation hierarchy.

The Term Loan is presented net of deferred issuance costs, which are amortized using the effective interest method over the term of the Term Loan. Gross deferred issuance costs at the inception of the Term Loan were $12.9 million and as of March 31, 2018 there were $7.7 million of unamortized deferred issuance costs.

Scheduled principal repayments of debt subsequent to March 31, 2018 are as follows:

(in thousands)	Amount
2018 (remaining)	$	6,637
2019	5,204
2020	4,250
2021	401,625
Total	$	417,716

16

Credit Facility

On July 31, 2015, in connection with the consummation of the Business Combination, AgroFresh Inc. as the borrower and its parent, AF Solutions Holdings LLC (“AF Solutions Holdings”), a wholly-owned subsidiary of the Company, as the guarantor, entered into a Credit Agreement with Bank of Montreal, as administrative agent (the “Credit Facility”). The Credit Facility consists of a $425 million term loan (the “Term Loan”), with an amortization equal to 1.00% per year, and a $25 million revolving loan facility (the “Revolving Loan”). The Revolving Loan includes a $10 million letter-of-credit sub-facility, issuances against which reduce the available capacity for borrowing. As of March 31, 2018, the Company has issued $0.5 million of letters of credit, against which no funds have been drawn. The Term Loan has a scheduled maturity date of July 31, 2021, and the Revolving Loan has a scheduled maturity date of July 31, 2019. The interest rates on borrowings under the facilities are either the alternate base rate plus 3.75% or LIBOR plus 4.75% per annum, with a 1.00% LIBOR floor (with step-downs in respect of borrowings under the Revolving Loan dependent upon the achievement of certain financial ratios). The obligations under the Credit Facility are secured by liens on substantially all of the assets of (a) AgroFresh Inc. and its direct wholly-owned domestic subsidiaries, and (b) AF Solutions Holdings, including the common stock of AgroFresh Inc.

The net proceeds of the Term Loan were used to fund a portion of the purchase price payable to R&H in connection with the Business Combination. Amounts available under the Revolving Loan may also be used for working capital, general corporate purposes, and other uses, all as more fully set forth in the Credit Agreement. At March 31, 2018, there was $414.3 million outstanding under the Term Loan and no balance outstanding under the Revolving Loan.

As of the Closing Date, the Company incurred approximately $12.9 million in debt issuance costs related to the Term Loan and $1.3 million in costs related to the Revolving Loan. The debt issuance costs associated with the Term Loan were capitalized against the principal balance of the debt, and the Revolving Loan costs were capitalized in Other Assets. All issuance costs will be accreted through interest expense for the duration of each respective debt facility. The interest expense related to the amortization of the debt issuance costs during the three months ended March 31, 2018 was approximately $0.6 million.

On November 18, 2015, the Credit Facility was amended. An existing provision in the credit agreement permitted the Company, subject to an overall cap of $12.0 million per fiscal year and certain other conditions, to pay dividends to the Company’s public stockholders and to redeem or repurchase, through July 31, 2016, the Company’s outstanding warrants for an aggregate purchase price of up to $10.0 million. The amendment expanded the scope of this provision to also permit the repurchase of shares of the Company’s outstanding common stock or other equity securities (subject to the same overall cap and other conditions).

Certain restrictive covenants are contained in the Credit Facility, which the Company was in compliance with as of March 31, 2018, other than certain covenants that would apply only to the extent  the Company draws against the Revolving Loan and has an outstanding balance at the end of a calendar quarter-end. There were no outstanding draws against the Revolving Loan as of March 31, 2018.

Beginning with the year ended December 31, 2016, the Company is required to prepay Term Loan Borrowings and Incremental Term Loan Borrowings in an aggregate amount equal to 50% of the Excess Cash Flow for the fiscal year; provided that such amount of the Excess Cash Flow in any fiscal year shall be reduced by (i) the aggregate amount of prepayments of Term Loans and Incremental Term Loans made, (ii) to the extent accompanied by permanent reductions of Revolving Commitments, the aggregate amount of prepayments of Revolving Loans (other than prepayments financed with the proceeds of Indebtedness), and (iii) repaid borrowings of Revolving Loans made on the Effective Date to account for any additional original issue discount or upfront fees that are implemented pursuant to the Fee Letter provided further that, prepayments of Term Loan Borrowings and Incremental Term Loan Borrowings shall only be required if 50% of the Excess Cash Flow for such fiscal year exceeds $5,000,000. There are no amounts due under this provision as of March 31, 2018.

11. Other Noncurrent Liabilities

The Company’s other noncurrent liabilities at March 31, 2018 and December 31, 2017 consisted of the following:

(in thousands)	March 31, 2018		December 31, 2017
Tax amortization benefit contingency	$	32,670	$	31,562
Other	6,523		6,943
Total other noncurrent liabilities	$	39,193	$	38,505

17

12. Severance

The Company expensed $0.3 million and $0.0 million for severance for the three months ended March 31, 2018 and March 31, 2017, respectively. This amount, which does not include stock compensation expense, was recorded in selling, general and administrative expense in the condensed consolidated statements of operations. As of March 31, 2018, the Company had $0.5 million of severance liability, of which $0.4 million will be paid out over the next year.

13. Stockholders’ Equity

The authorized common stock of the Company consists of 400,000,000 shares with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share of common stock. As of March 31, 2018, there were 50,394,366 shares of common stock outstanding. As of March 31, 2018, there were warrants to purchase 15,983,072 shares of the Company’s common stock outstanding at a strike price of $11.50. Of the 15,983,072 warrants, 9,823,072 were issued as part of the units sold in the Company's initial public offering in February 2014 (1,201,928 warrants were subsequently repurchased during 2015) and 6,160,000 warrants were sold in a private placement at the time of such public offering.

On November 18, 2015, the Company announced that its board of directors had authorized a stock repurchase program (the “Repurchase Program”). The Repurchase Program authorized the Company to repurchase in the aggregate up to $10 million of the Company’s publicly-traded shares of common stock. The Repurchase Program was in effect for a period of one year, until November 17, 2016. Under the Repurchase Program, the Company repurchased 661,381 shares of its common stock for $3.9 million, which shares are classified as treasury stock on the condensed consolidated balance sheet.

In connection with and as a condition to the consummation of the Business Combination, the Company issued R&H one share of Series A Preferred Stock. R&H, voting as a separate class, is entitled to appoint one director to the Company’s board of directors for so long as R&H beneficially holds 10% or more of the aggregate amount of the outstanding shares of common stock and non-voting common stock of the Company. The Series A Preferred Stock has no other rights.

Simultaneously with the consummation of the Business Combination, the Company issued 4,878,048 shares of common stock at a price of $10.25 per share in a private placement to raise an aggregate of $50 million of additional equity.

14. Stock-based Compensation

Stock compensation expense for both equity-classified and liability-classified awards for the three months ended March 31, 2018 and March 31, 2017 was $0.6 million and $0.2 million, respectively. Stock compensation expense is recognized in cost of goods sold, selling, general and administrative expenses, and research and development expenses. At March 31, 2018, there was $3.5 million of unrecognized compensation cost relating to outstanding unvested equity instruments expected to be recognized over the weighted average period of 1.7 years.

On March 29, 2018, the Company granted the following share-based awards to members of management employed in the United States. These awards will be settled in shares of the Company's common stock and are equity-classified. The grant date fair value of these awards will be recognized on a straight-line basis over the vesting period. The performance-based restricted stock units each have a performance period that ends on December 31, 2020 and the other awards vest ratably on the first, second, and third anniversaries of the grant date.

Performance-based restricted stock units	195,650
Time-based restricted stock	149,700
Options	134,250
Total	479,600

On March 29, 2018, the Company also granted the following share-based awards to members of management employed in countries outside of the United States. These awards will be settled in cash and are liability-classified. Therefore, the fair value of these liability-classified awards will be re-measured on each balance sheet date. The performance-based phantom shares each have a performance period that ends on December 31, 2020 and the other awards vest ratably on the first, second, and third anniversaries of the grant date.

Performance-based phantom shares	24,450
Service-based phantom shares	41,750
Stock appreciation rights	2,800
Total	69,000

18

The performance-based restricted stock units and phantom shares were valued with a Monte Carlo simulation model using the assumptions in the table below. Based on these assumptions, the grant date fair value of the performance-based restricted stock units and phantom shares was estimated to be $7.28 per share.

Volatility	69.9		%
Risk-free interest rate	2.39		%
Dividend yield	0.00		%
Grant date stock price	$	7.35
Performance period	3 years

The stock options and stock appreciation rights were valued with a Black-Scholes option pricing model using the assumptions in the table below. Since the Company has limited historical volatility information available, the expected volatility was based on actual volatility for comparable public companies projected over the expected term of the Options and the actual volatility for the Company since the Business Combination. The risk-free interest rate was based on the U.S. Treasury yield curve at the time of the grant over the expected term of the Options. The expected life was estimated using the simplified method. Based on these assumptions, the grant-date fair value of the stock options and stock appreciation rights was estimated to be $3.57.

Volatility	48.80		%
Risk-free interest rate	2.56		%
Dividend yield	0.00		%
Grant date stock price	$	7.35
Expected term	6 years

The fair value of the time-based restricted stock and the service-based phantom shares is equal to the closing price of the Company’s common stock on the grant date of the awards.

15. Earnings Per Share

Basic loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding for the period. Due to the loss in the quarter, dilutive loss per share is the same as basic loss per share as the adjustment for the assumed issuance of all potentially dilutive share-based awards, including stock options, restricted stock and warrants would be anti-dilutive.

The following is a reconciliation of the weighted-average common shares outstanding used for the computation of basic and diluted net loss per common share:

	Three Months Ended March 31, 2018	Three Months Ended March 31, 2017
Basic weighted-average common shares outstanding	49,741,593	49,661,469
Effect of dilutive options, performance stock units and restricted stock	—	—
Dilute weighted-average shares outstanding	49,741,593	49,661,469

Securities that could potentially be dilutive are excluded from the computation of diluted earnings per share when a loss from continuing operations exists or when the exercise price exceeds the average closing price of the Company's common stock during the period, because their inclusion would result in an anti-dilutive effect on per share amounts.

19

The following represents amounts that could potentially dilute basic earnings per share in the future:

(in thousands, except share data)	Three Months Ended March 31, 2018	Three Months Ended March 31, 2017
Stock-based compensation awards(1):
Stock options	63,019	926,898
Restricted stock to non-directors	610,642	797,401
Restricted stock to directors	122,929	78,754
Warrants:
Private placement warrants	6,160,000	6,160,000
Public warrants	9,823,072	9,823,072

———————————————————————————————

(1) SARs and Phantom Shares are payable in cash so will therefore have no impact on number of shares

Warrants and options are considered anti-dilutive and excluded when the exercise price exceeds the average market value of the Company’s common stock price during the applicable period. Performance share units are considered anti-dilutive if the performance targets upon which the issuance of the shares is contingent have not been achieved and the respective performance period has not been completed as of the end of the current period.

16. Income Taxes

The provision for income taxes consists of provisions for federal, state, and foreign incomes taxes. The effective tax rates for the periods ended March 31, 2018, and March 31, 2017, reflect the Company’s expected tax rate on reported income from continuing operations before income tax and tax adjustments. The Company operates in a global environment with significant operations in the U.S. and various other jurisdictions outside the U.S. Accordingly, the consolidated income tax rate is a composite rate reflecting the Company’s earnings and the applicable tax rates in the various jurisdictions where the Company operates.

On December 22, 2017, the Tax Cuts and Jobs Act (“TCJA”) was enacted in the U.S. The TCJA represents sweeping changes in U.S. tax law. Among other changes in tax law, the TCJA permanently reduced the U.S. corporate income tax rate to 21% beginning in 2018; imposed a one-time repatriation tax on deferred foreign earnings; established a participation exemption system by allowing a 100% dividends received deduction on qualifying dividends paid by foreign subsidiaries; limited deductions for net interest expense; and expanded the U.S. taxation of foreign earned income to include “global intangible low-taxed income” (“GILTI”).

As permitted by SAB No. 118, the tax benefit recorded in the fourth quarter of 2017 due to the enactment of the TCJA was considered “provisional”, based on reasonable estimates. The Company is continuing to collect and analyze detailed information about the earnings and profits of its non-U.S. subsidiaries, the related taxes paid, the amounts which could be repatriated, the foreign taxes which may be incurred on repatriation, and the associated impact of these items under the TCJA. The Company may record adjustments to refine those estimates during the measurement period, as additional analysis is completed. No adjustments were recorded during the first fiscal quarter of 2018.

The TCJA transitions the U.S. from a worldwide tax system to a territorial tax system. Under previous law, companies could indefinitely defer U.S. income taxation on unremitted foreign earnings. The TCJA imposes a one-time repatriation tax on deferred foreign earnings of 15.5% for liquid assets and 8% for illiquid assets, payable in defined increments over eight years. As a result of this requirement, the Company recognized provisional tax expense of $0.5 million in 2017, and provisionally expects to pay $0.3 million, net of estimated applicable foreign tax credits, and after utilization of FTC Credit carryforwards. These previously deferred foreign earnings may now be repatriated to the U.S. without additional U.S. federal taxation. However, any such repatriation could incur withholding and other foreign taxes in the source and intervening foreign jurisdictions, and certain U.S. state taxes. The Company continues to not recognize any U.S. income or foreign withholding taxes for the differences between the financial reporting and tax basis of the investments in foreign subsidiaries that are indefinitely reinvested outside the U.S. This amount may be recognized upon a sale or liquidation.

The Company's effective tax rate for the three months ended March 31, 2018 was (38.4)%, compared to the effective tax rate of (13.0)% for the three months ended March 31, 2017.

The effective tax rate for the three months ended March 31, 2018 differs from the U.S. statutory tax rate of 21%, due to unbenefited losses and certain provisions of the TCJA. The unbenefited losses related to the elimination of intercompany profit in inventory. The provisions of the TCJA are interrelated and the impact of any specific provision cannot be isolated. The Company operates at a pre-tax loss and the

20

reduction in the federal tax rate to 21% reduces the tax benefit recorded. In addition, the inclusion of GILTI income and the limitation and deductibility of interest expense increased the effective tax rate. The Company has elected to account for GILTI tax in the period in which it is incurred, and therefore did not provide any deferred taxes in the consolidated financial statements at December 31, 2017.

17. Commitments and Contingencies

The Company is currently involved in various claims and legal actions that arise in the ordinary course of business. The Company has recorded reserves for loss contingencies based on the specific circumstances of each case. Such reserves are recorded when it is probable that a loss has been incurred as of the balance sheet date and can be reasonably estimated. Although the results of litigation and claims can never be predicted with certainty, the Company does not believe that the ultimate resolution of these actions will have a material adverse effect on the Company’s business, financial condition or results of operations.

Purchase Commitments

The Company has various purchasing contracts for contract manufacturing and research and development services which are based on the requirements of the business. Generally, the contracts are at prices not in excess of current market prices and do not commit the business to obligations outside the normal customary terms for similar contracts.

21

18. Fair Value Measurements

Liabilities Measured at Fair Value on a Recurring Basis

The following table presents the fair value of the Company’s financial instrument liability/(asset) that are measured at fair value on a recurring basis as of March 31, 2018:

(in thousands)	Level 1		Level 2			Level 3		Total
Tax amortization benefit contingency(1)	$	—	$	—		$	44,490	$	44,490
Contingent consideration(2)	—		—			831		831
Interest rate contract (3)	—		(2,244		)	—		(2,244		)
Stock appreciation rights(4)	—		—			176		176
Phantom shares(5)	—		—			286		286
Total	$	—	$	(2,244	)	$	45,783	$	43,539

The following table presents the fair value of the Company’s financial instruments that are measured at fair value on a recurring basis as of December 31, 2017:

(in thousands)	Level 1		Level 2		Level 3		Total
Tax amortization benefit contingency(1)	$	—	$	—	$	43,382	$	43,382
Contingent consideration(2)	—		—		693		693
Interest rate contract (3)	—		456		—		456
Stock appreciation rights(4)	—		—		268		268
Phantom shares(5)	—		—		186		186
Total	$	—	$	456	$	44,529	$	44,985

———————————————————————————————

(1) The fair value of the tax amortization benefit contingency is measured using an income approach based on the Company’s best estimate of the undiscounted cash payments to be made, with the current portion tax effected at 35.3% and the non-current portion tax effected at 21.5% due to the Tax Cuts and Job Act (TCJA) of December 2017 enacted in the U.S and discounted to present value utilizing an appropriate market discount rate. Per the April 4, 2017 Amendment Agreement, payments due to Dow under the Tax Receivable Agreement was reduced from 85% to 50% of the applicable tax savings realized by the Company. The valuation technique used did not change during the three months ended March 31, 2018.

(2) The fair value of the contingent consideration related to the Tecnidex acquisition.

(3) The derivative assets and liabilities relate to an interest rate derivative that is measured at fair value using observable market inputs such as interest rates, our own credit risks as well as an evaluation of the counterparts' credit risks. The fair value for the three months ended March 31, 2018 resulted in an asset balance while the three months ended December 31, 2017 is in a liability balance.

(4) The fair value of the stock appreciation rights was measured using a Black Scholes pricing model during the three months ended March 31, 2018. The valuation technique used did not change during the three months ended March 31, 2018.

(5) The fair value of phantom shares are based on the fair value of the Company's common stock. The valuation technique used did not change during the three months ended March 31, 2018.

There were no transfers between Level 1 and Level 2 and no transfers out of Level 3 of the fair value hierarchy during the three months ended March 31, 2018.

At March 31, 2018, the Company evaluated the amount recorded under the Term Loan and determined that the fair value was approximately $417.5 million. The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable approximate fair value.

22

Changes in Financial Instruments Measured at Level 3 Fair Value on a Recurring Basis

The following table presents the changes during the period presented in our Level 3 financial instrument liability/(asset) that are measured at fair value on a recurring basis.

(in thousands)	Tax amortization benefit contingency		Contingent consideration related to acquisition		Interest rate contract			Stock appreciation rights			Phantom shares		Total
Balance, December 31, 2017	$	43,382	$	693	$	456		$	268		$	186	$	44,985
Accretion	1,108		—		—			—			—		1,108
Stock compensation expense	—		—		—			(92		)	100		8
Mark-to-market adjustment	—		138		(2,700		)	—			—		(2,562		)
Balance, March 31, 2018	$	44,490	$	831	$	(2,244	)	$	176		$	286	$	43,539

23

ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

As used in this Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”), the terms “Company,” “AgroFresh,” “we,” “us” and “our” refer to AgroFresh Solutions, Inc. and its consolidated subsidiaries, unless the context otherwise requires or it is otherwise indicated.

The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto contained elsewhere in this Report. 

This MD&A contains the financial measure EBITDA, which is not presented in accordance with accounting principles generally accepted in the United States of America ("GAAP"). This non-GAAP financial measure is being presented because management believes that it provides readers with additional insight into the Company’s operational performance relative to earlier periods and relative to its competitors. EBITDA is a key measure used by the Company to evaluate its performance. The Company does not intend for this non-GAAP financial measure to be a substitute for any GAAP financial information. Readers of this MD&A should use this non-GAAP financial measure only in conjunction with the comparable GAAP financial measure. A reconciliation of EBITDA to the most comparable GAAP measure is provided in this MD&A.

Note Regarding Forward-Looking Statements

All statements other than statements of historical fact included in this Report including, without limitation, statements in this MD&A regarding the Company's financial position, business strategy and the plans and objectives of management for future operations, are forward looking statements. When used in this Report, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to the Company or its management, identify forward looking statements. Such forward looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, management. Actual results and/or the timing of events could differ materially from those contemplated by these forward-looking statements due to a number of factors, including those discussed under the heading “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2017 (the "2017 Form 10-K") as well as the update to those Risk Factors disclosed in Part II, Item 1A of this Report. Any forward-looking statements included in this Report are based only on information currently available to the Company and speak only as of the date on which such statements are made. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. All subsequent written or oral forward-looking statements attributable to the Company or persons acting on behalf of the Company are qualified in their entirety by this paragraph.

Business Overview

AgroFresh is a global leader in delivering innovative food preservation and waste reduction solutions for fresh produce. The Company is empowering the food industry with Smarter Freshness^TM, a range of integrated solutions designed to help growers, packers and retailers improve produce freshness and quality while reducing waste. AgroFresh’s solutions range from pre-harvest with Harvista^TM and LandSpring^TM to its marquee SmartFresh^TM Quality System, which includes SmartFresh^TM, AdvanStore^TM and ActiMist^TM, working together to maintain the quality of stored produce. AgroFresh has a controlling interest in Tecnidex Fruit Protection, S.A.U. (“Tecnidex”), a leading provider of post-harvest fungicides, waxes, coatings and biocides for the citrus market. Additionally, the company’s initial retail solution, RipeLock^TM, optimizes banana ripening for the benefit of retailers and consumers. AgroFresh has key products registered in over 45 countries, supports approximately 3,700 direct customers and services over 25,000 storage rooms globally.

In December 2017, AgroFresh acquired a controlling interest in Tecnidex. With this acquisition, AgroFresh expanded its industry-leading post-harvest presence into additional crops, and increased its penetration of the produce market in southern Europe, Latin America and Africa. For over 35 years, Tecnidex has been helping fruit and vegetable producers offer clean, safe and high-quality products to its regional customers in 18 countries. Through its portfolio of post-harvest products, technology, consulting, and after-sale services, Tecnidex improves the quality and value of its clients’ fruit and vegetables while respecting the environment. Tecnidex is based in Valencia, Spain. Tecnidex further diversifies AgroFresh’s revenue by expanding our ability to provide solutions and service to the citrus industry.

Freshness is the most important driver of consumer satisfaction when it comes to produce, and, at the same time, food waste is a major issue in the industry. About one third of the total food produced worldwide is lost or wasted each year. Nearly 45 percent of all fresh fruits and vegetables, 40 percent of apples and 20 percent of bananas, are lost to spoilage. AgroFresh plays a key role in the value chain by offering products and services that maintain produce freshness and reduce waste.

AgroFresh’s current principal product, SmartFresh, regulates the post-harvest ripening effects of ethylene, the naturally occurring plant hormone that triggers ripening in certain fruits and vegetables. SmartFresh is naturally biodegradable, leaves no detectable residue, and has been approved for use by many domestic and global regulatory organizations. Harvista extends the Company’s proprietary technology

24

into pre-harvest management of pome fruit such as apples, pears and cherries. AdvanStore is an atmospheric monitoring system that leverages the Company’s extensive understanding of fruit physiology, fruit respiration, current controlled atmosphere technology, and new proprietary diagnostic tools to provide improved and real-time guidance to producers and packers of fresh produce regarding storage conditions so corrective measures can be made on a more timely basis. RipeLock combines the technology behind SmartFresh with modified atmosphere packaging designed specifically to preserve quality during transportation and to extend the yellow shelf life of bananas and potentially other fruits. LandSpringis an innovative 1-MCP technology targeted to transplanted vegetable seedlings. It is currently registered for use on tomato, peppers, and 14 other crops in the US. It reduces transplant shock, resulting in less seedling mortality and faster crop establishment, which leads to a healthier crop and improved yields.

AgroFresh’s business is highly seasonal, driven by the timing of harvests in the northern and southern hemispheres. The first half of the year is when the southern hemisphere harvest occurs, and the second half of the year is when the northern hemisphere harvest occurs. Since the northern hemisphere harvest of our two core crops of apples and pears is typically larger, a significant portion of our sales and profits are historically generated in the second half of the year. In addition to this seasonality, factors such as weather patterns may impact the timing of the harvest within the two halves of the year.

AgroFresh is a former blank check company that completed its initial public offering on February 19, 2014. Upon the closing of the Business Combination with Dow on July 31, 2015, the Company changed its name to AgroFresh Solutions, Inc. The Company paid Dow cash consideration of $635 million and issued Dow 17.5 million shares of common stock at a deemed value of $12 per share. The transaction included a liability to Dow to deliver a variable number of warrants between the closing and April 2016, which obligation was terminated pursuant to a letter agreement entered into on April 4, 2017. The cash consideration was funded through our initial public offering, a term loan, and a private placement of 4.9 million shares of common stock that yielded $50 million of proceeds. The transaction also had an earn-out feature whereby Dow was entitled to receive a deferred payment of $50 million in March 2018 if AgroFresh achieved a specified average level of Business EBITDA (as defined in the Stock Purchase Agreement related to the Business Combination) over 2016 and 2017. The specified level of Business EBITDA was not achieved and, accordingly, the earn-out feature is no longer payable. In addition, pursuant to a tax receivables agreement entered into in connection with the Business Combination, as amended in April 2017, Dow is entitled to receive 50% of the tax savings, if any, that the Company realizes as a result of the increase in the tax basis of assets acquired pursuant to the Business Combination.

In connection with the closing of the Business Combination, AgroFresh entered into a Transition Services Agreement with Dow. Under the agreement, Dow provided AgroFresh a suite of services for a period of time ranging from six months to five years depending on the service. While most of the Dow-provided services are complete as of December 31, 2017 certain services are expected to continue through 2018. The agreement also provided for a $5 million execution fee that was paid to Dow at the closing of the Business Combination.

Factors Affecting the Company’s Results of Operations

The Company’s results of operations are affected by a number of external factors. Some of the more important factors are briefly discussed below.

Demand for the Company’s Offerings

The Company services customers in over 45 countries and derives its revenue by assisting growers, packers and retailers to maximize the value of their crops brought to market and customers. The Company's products and services add value to customers by reducing food spoilage and extending the life of perishable fruits. The U.S. Food and Agriculture Organization has estimated that a growing global population will require a near doubling of food production in developing countries by 2050 to meet the expected demand of a worldwide population of 9 billion people.

This global trend, among others, creates demand for the Company’s solutions. The Company’s offerings are currently protected by patents on, among other things, the encapsulation of the active ingredient, 1-MCP.

The global produce market is a function of both the size and the yield of the crop harvested; variations in either will affect total production. Given the nature of the agricultural industry, weather patterns may impact total production and the Company's resulting commercial opportunities. The Company supports a diverse customer base whose end markets vary due to the type of fruit and quality of the product demanded in their respective markets. Such variation across end markets also affects demand for the Company’s services.

Customer Pricing

The Company’s offerings are priced based on the value they provide to the Company’s customers. From time to time, the Company adjusts the pricing of its offering depending on the volume of fruit treated, or in order to address specific market trends. The SmartFresh Quality System continues to expand its platform of services, which may have an impact on price. The Company provides a value-added service and does not typically price its products in relation to any underlying cost of materials; therefore, its margins can fluctuate with

25

changes in the costs to provide its services to customers. The Company’s pricing may include rebate arrangements with customers in exchange for mutually beneficial long-term relationships and growth.

Direct Service Model

AgroFresh offers a direct service model for the Company’s commercially available products, including SmartFresh and Harvista. Sales and sales support personnel maintain direct face-to-face relationships with customers year round. Technical sales and support personnel work directly with customers to provide value-added advisory services regarding the application of SmartFresh. The actual application of SmartFresh is performed by service providers that are typically third-party contractors. The Harvista application service, through both aerial and ground application, is also administered by third-party service providers or made by our customers directly. The combination of SmartFresh and Harvista treatments are designed to provide the best results to customers.

The Company is shifting the terms of its contracts with service providers from annual renewal periods to two or three year durations in order to have greater certainty that experienced applicators will be available for upcoming harvest seasons. Most of the Company’s service providers are operating under multi-year contracts. Management believes the quality and experience of its service providers deliver clear commercial benefits.

Seasonality

The Company’s operations are subject to seasonal variation due to the timing of the growing seasons around the world. Northern Hemisphere growers typically harvest from August through November, and Southern Hemisphere growers typically harvest from late January to early May. Since the majority of the Company’s sales are in Northern Hemisphere countries, a proportionately greater share of its revenue is realized during the second half of the year. There are also variations in the seasonal demands from year to year depending on weather patterns and crop size. This seasonality and variations in seasonal demand could impact the ability to compare results between periods. As the Company diversifies into other crops and becomes less dependent on pome fruit, the Company expects that the impacts of seasonality will lessen.

Foreign Currency Exchange Rates

With a global customer base and geographic footprint, the Company generates revenue and incurs costs in a number of different currencies, with the Euro comprising the most significant non-U.S. currency. Fluctuations in the value of these currencies relative to the U.S. dollar can increase or decrease the Company’s overall revenue and profitability as stated in U.S. dollars, which is the Company’s reporting currency. In certain instances, if sales in a given geography have been adversely impacted on a long-term basis due to foreign currency depreciation, the Company has been able to adjust its pricing so as to mitigate the impact on profitability.

Domestic and Foreign Operations

The Company has both domestic and foreign operations. Fluctuations in foreign exchange rates, regional growth-related spending in research and development (“R&D”) and marketing expenses, and changes in local selling prices, among other factors, may impact the profitability of foreign operations in the future.

Critical Accounting Policies and Use of Estimates

Critical accounting policies are those accounting policies that can have a significant impact on the presentation of our financial condition and results of operations and that require the use of complex and subjective estimates based upon management’s judgment. Because of the uncertainty inherent in such estimates, actual results may differ materially from these estimates. Aside from the adoption of ASC 606, there have been no material changes to our critical accounting policies and estimates previously disclosed in the 2017 Form 10-K. For a description of our critical accounting policies and estimates as well as a listing of our significant accounting policies, see “Management's Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Policies and Use of Estimates” and “Note 2 - Basis of Presentation and Summary of Significant Accounting Policies” in the 2017 Form 10-K. 

26

Results of Operations

The following table summarizes the results of operations for both the three months ended March 31, 2018 and March 31, 2017:

(in thousands)	Three Months Ended March 31, 2018			Three Months Ended March 31, 2017
Net sales	$	38,351		$	32,730
Cost of sales (excluding amortization, shown separately below)	10,846			5,839
Gross profit	27,505			26,891
Research and development expenses	3,069			3,297
Selling, general, and administrative expenses	16,311			16,431
Amortization of intangibles	10,939			10,445
Change in fair value of contingent consideration	138			215
Operating loss	(2,952		)	(3,497		)
Other income	70			40
Gain on foreign currency exchange	1,931			3,103
Interest expense, net	(8,355		)	(10,293		)
Loss before income taxes	(9,306		)	(10,647		)
Provision for income taxes	3,570			1,382
Net loss including non-controlling interests	$	(12,876	)	$	(12,029	)
Less: Net income attributable to non-controlling interests	91			—
Net loss attributable to AgroFresh Solutions, Inc	$	(12,967	)	$	(12,029	)

Comparison of Results of Operations for the three months ended March 31, 2018 compared to the three months ended March 31, 2017.

Net Sales

Net sales were $38.4 million for the three months ended March 31, 2018 as compared to net sales of $32.7 million for the three months ended March 31, 2017. Tecnidex accounted for $5.6 million of sales in the quarter. The additional increase in net sales was driven by increased penetration of SmartFresh on apples in Brazil and other crops throughout Latin America and continued increases of Harvista sales in Argentina, offsetting the year over year lower crop sizes in South Africa (due to drought), Brazil, Chile and Argentina.

Cost of Sales

Cost of sales was $10.8 million for the three months ended March 31, 2018 as compared to $5.8 million for the three months ended March 31, 2017. Gross profit margin was 71.7% in the first three months of 2018 versus 82.2% in the first three months of 2017. The decrease in margin was primarily driven by an unfavorable mix with the increase in Harvista sales, the addition of Tecnidex and the deferral of revenue.

Research and Development Expenses

Research and development expenses were $3.1 million for the three months ended March 31, 2018 as compared to $3.3 million for the three months ended March 31, 2017. The decrease in research and development expenses reflects more targeted research activities in 2018.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were $16.3 million for the three months ended March 31, 2018 compared to $16.4 million for the three months ended March 31, 2017. This decrease in selling, general and administrative expenses was primarily driven by lower non-recurring costs as efficiency and productivity improvements offset Tecnidex related increases as well as on going expense associated strategic initiatives and MirTech.

27

Amortization of Intangibles

Amortization of intangible assets was $10.9 million for the three months ended March 31, 2018 compared to $10.4 million for the three months ended March 31, 2017.

Change in Fair Value of Contingent Consideration

The Company recorded a $0.1 million loss in the three months ended March 31, 2018 related to a change in the fair value of contingent consideration, as compared to a $0.2 million loss in the three months ended March 31, 2017. As discussed in Note 3 to the unaudited condensed consolidated financial statements, pursuant to the Business Combination, the Company entered into various forms of contingent consideration, including the warrant consideration, and the tax amortization benefit contingency. These liabilities are measured at fair value each reporting date and any mark-to-market fluctuations are recognized in earnings.

Interest Expense, Net

Interest expense was $8.4 million for the three months ended March 31, 2018, as compared to $10.3 million for the three months ended March 31, 2017. Lower accretion of the Tax Receivables Agreement of $2.5 million accounted for most of the decrease in interest expense.

Income taxes

Income tax expense was $3.6 million for the three months ended March 31, 2018 compared to $1.4 million for the three months March 31, 2017. During the three months ended March 31, 2018, certain losses occurred that did not receive a tax benefit. The unbenefited losses related to the elimination of intercompany profit in inventory. In addition to the unbenefited losses, certain provisions of the Tax Cuts and Jobs Act (“TCJA”) impacted the Company. The TCJA reduced the corporate income tax rate to 21% which reduced the overall tax benefit for the Company. Other provisions like the limitation and deductibility of interest expense and inclusion of GILTI income had an immaterial impact on the effective tax rate for the three months ended March 31, 2018, but the deductibility of interest expense may have a more material impact within the U.S. jurisdiction in future periods.

Non-GAAP Measure

The following table sets forth the non-GAAP financial measure of EBITDA. The Company believes this non-GAAP financial measure provides meaningful supplemental information as it is used by the Company’s management to evaluate the Company’s performance, is more indicative of future operating performance of the Company, and facilitates a better comparison among fiscal periods, as the non-GAAP measure excludes items that are not considered core to the Company’s operations. These non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP.

The following is reconciliation between the non-GAAP financial measure of EBITDA to its most directly comparable GAAP financial measure, net loss:

(in thousands)	Three Months Ended March 31, 2018			Three Months Ended March 31, 2017
GAAP net loss	$	(12,876	)	$	(12,029	)
Provision for income taxes	3,570			1,382
Interest expense(1)	8,355			10,293
Depreciation and amortization	11,273			10,978
Non-GAAP EBITDA	$	10,322		$	10,624

———————————————————————————————

(1)    Interest on the term loan and accretion for debt discounts, debt issuance costs and contingent consideration.

28

Liquidity and Capital Resources

Cash Flow

(in thousands)	Three Months Ended March 31, 2018		Three Months Ended March 31, 2017
Net cash provided by operating activities	3,417		8,836
Net cash used in investing activities	(1,905	)	(1,364	)
Net cash used in financing activities	(11,407	)	(1,063	)

Cash provided by operating activities was $3.4 million for the three months ended March 31, 2018, as compared to $8.8 million for the three months ended March 31, 2017. In 2018, net loss before non-cash depreciation and amortization and changes in fair value of contingent consideration (including accretion) was $(1.5) million. Other non-cash charges included stock-based compensation of $0.6 million, $0.6 million of deferred financing costs, a $3.6 million increase in the net deferred taxes, and other non-cash items of $0.4 million. Additionally, the change in net operating assets was $(0.4) million in 2018. For the three months ended March 31, 2017, net income before non-cash depreciation and amortization and changes in fair value of contingent consideration (including accretion) was $2.9 million. Other non-cash charges included stock-based compensation of $0.2 million, $0.6 million of deferred financing costs, and other non-cash items of $0.6 million. Additionally, the change in net operating assets was $4.6 million for the three months ended March 31, 2017.

Cash used in investing activities was $(1.9) million for the three months ended March 31, 2018, as compared to $(1.4) million for the three months ended March 31, 2017. Cash used in investing activities in 2018 was for the purchase of fixed assets and leasehold improvements of $(1.9) million. Cash used in 2017 was for the purchase of fixed assets and leasehold improvements, of $(1.0) million and an investment of $(0.4) million.

Cash used in financing activities was $(11.4) million for the three months ended March 31, 2018, as compared to $(1.1) million for the three months ended March 31, 2017. Cash used in financing activities in 2018 was for the payment of Dow liabilities of $(10.0) million along with the repayment of debt in the amount of $(1.4) million. Cash used in 2017 was for the repayment of debt in the amount of $(1.1) million.

Liquidity

Since the consummation of the Business Combination we have financed our operations primarily through the sales of our products and services. At March 31, 2018, we had $57.0 million of cash and cash equivalents, compared to $64.5 million at December 31, 2017.

On July 31, 2015, the Company consummated the Business Combination, pursuant to which the Company issued 17,500,000 shares of common stock at a deemed value of $12.00 per share and paid cash consideration of $635.0 million at the closing. The cash consideration was funded through the Company's initial public offering, the Term Loan (defined below) and the sale of our PIPE shares (defined below).

Term Loan

On July 31, 2015, certain of our subsidiaries entered into a Credit Agreement with Bank of Montreal, as administrative agent (the “Credit Facility”). The Credit Facility consists of a $425 million term loan (the “Term Loan”), with an amortization equal to 1.00% per year, and a $25 million revolving loan facility (the “Revolving Loan”). The Revolving Loan includes a $10.0 million letter-of-credit sub-facility, issuances against which reduce the available capacity for borrowing. As of March 31, 2018, the Company had issued $0.5 million of letters of credit, against which no funds have been drawn. The Term Loan has a scheduled maturity date of July 31, 2021, and the Revolving Loan has a scheduled maturity date of July 31, 2019. The interest rates on borrowings under the facilities are either the alternate base rate plus 3.75%, or LIBOR plus 4.75% per annum, with a 1.00% LIBOR floor (with step-downs in respect of borrowings under the Revolving Loan dependent upon the achievement of certain financial ratios). The obligations under the Credit Facility are secured by liens on substantially all of the assets of (a) AgroFresh Inc. and its direct wholly-owned domestic subsidiaries, and (b) AF Solutions Holdings, including the common stock of AgroFresh Inc.

On November 18, 2015, the Credit Facility was amended. An existing provision in the credit agreement permitted the Company, subject to an overall cap of $12.0 million per fiscal year and certain other conditions, to pay dividends to the Company’s public stockholders and to redeem or repurchase, through July 31, 2016, the Company’s outstanding warrants for an aggregate purchase price of up to $10.0 million. The amendment expanded the scope of this provision to also permit the repurchase of shares of the Company’s outstanding common stock or other equity securities (subject to the same overall cap and other conditions).

29

The net proceeds of the Term Loan were used to fund a portion of the purchase price payable to Rohm and Haas Company ("R&H"), a subsidiary of Dow, in connection with the Business Combination. Amounts available under the Revolving Loan may also be used for working capital, general corporate purposes, and other uses, all as more fully set forth in the Credit Facility.

As of March 31, 2018, the Company was in compliance with the senior secured net leverage covenant and the other covenants in the facility, other than covenants that apply only to the Company’s ability to borrow under the Revolving Loan (excluding letters of credit). The Company is not currently able to access the Revolving Loan (other than for letters of credit) as a result of non-compliance with certain covenants in the facility applicable solely to the Revolving Loan.

As of the Closing Date the Company incurred approximately $12.9 million in debt issuance costs related to the Term Loan and $1.3 million in costs related to the Revolving Loan. The debt issuance costs associated with the Term Loan were capitalized against the principal balance of the debt, and the Revolving Loan costs were capitalized in Other Assets. All issuance costs will be accreted through interest expense for the duration of each respective debt facility. The accretion in interest expense during the three months ended March 31, 2018 was approximately $0.6 million.

PIPE Shares

In connection with the closing of the Business Combination, the Company issued an aggregate of 4,878,000 shares of common stock, for an aggregate purchase price of $50.0 million, in a private placement (“PIPE”).

Off-Balance Sheet Arrangements

As of March 31, 2018, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not have any commitments or contractual obligations other than as detailed below. We have not guaranteed any debt or commitments of other entities or entered into any options on non-financial assets.

Contingent Consideration

In connection with the Business Combination pursuant to the Purchase Agreement and subsequently modified by the Amendment Agreement, Dow is entitled to receive future contingent consideration and other payments from the Company in relation to a Tax Receivables Agreement under which the Company is required to pay annually to Dow 50% of the amount of the tax savings, if any, in U.S. Federal, state and local income tax or franchise tax that the Company actually realizes as a result of the increase in tax basis of the AgroFresh Inc. assets resulting from a section 338(h)(10) election that the Company and Dow made in connection with the Business Combination; See Note 3 to the unaudited condensed consolidated financial statements contained in this Report for further discussion of contingent consideration in connection with the Business Combination.

30

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Risk

Our exposure to interest rate risk for changes in interest rates relates primarily to our Term Loan and Revolving Loan. The Term Loan and Revolving Loan bear interest at floating rates. For variable rate debt, interest rate changes generally do not affect the fair market value of such debt, but do impact future earnings and cash flows, assuming other factors are held constant.

In December 2017 we entered into an interest rate swap agreement that qualified for and is designated as a cash flow hedge. We currently have a cash flow hedge with an amount equal to approximately 60% of our current outstanding Term Loan covering the next 33 months. Holding debt levels constant, a 100 basis point increase in the effective interest rates would have increased the Company’s interest expense by $1.7 million for the three months ended March 31, 2018.

Foreign Currency Risk

A portion of the Company’s operations consists of manufacturing and sales activities in foreign jurisdictions. As a result, the Company’s financial results could be significantly affected by factors such as changes in foreign currency exchange rates or weak economic conditions in the foreign markets in which the Company distributes its products or services. The Company’s operating results are exposed to changes in exchange rates between the US dollar and various foreign currencies. As we expand internationally, our results of operations and cash flows will become increasingly subject to changes in foreign currency exchange rates.

We have not used forward contracts or currency borrowings to hedge our exposure to foreign currency risk. Foreign currency risk can be quantified by estimating the change in results of operations or financial position resulting from a hypothetical 10% adverse change in foreign exchange rates. We believe such a change would generally not have a material impact on our financial position, but could have a material impact on our results of operations. Holding other variables constant (such as interest rates and debt levels), if the U.S. dollar appreciated by 10% against the foreign currencies used by our operations in the first three months of 2018, revenues would have decreased by approximately $4.0 million and EBITDA would have decreased by approximately $2.0 million for the three months ended March 31, 2018.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

An evaluation was carried out under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based on the evaluation of our disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act was recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information required to be disclosed is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Changes in Internal Controls

Effective January 1, 2018, we adopted the new revenue standard ASC 606. We have implemented new accounting processes related to revenue recognition and related disclosures, including related control activities.

 Effective January 12, 2018 the Company completed the process of installing a new ERP system. This new stand alone ERP system replaced the Dow hosted ERP. This effectively ends the transition services agreement whereby Dow provided IT support to the Company. The implementation of this new ERP system involves changes to the Company’s procedures for internal control over financial reporting. The Company followed a system implementation process that required significant pre-implementation planning, design, and testing. The Company has also conducted and will continue to conduct extensive post-implementation monitoring and process modifications to ensure that internal controls over financial reporting are properly designed.

There were no other changes in the Company's internal control over financial reporting that occurred during the Company's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

31

PART II- OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

From time to time we are named as a defendant in legal actions arising from our normal business activities. Although we cannot predict with certainty the ultimate resolution of lawsuits, investigations and claims asserted against us, we do not believe any currently pending legal proceeding to which we are a party will have a material adverse effect on our business, prospects, financial condition, cash flows or results of operations.

ITEM 1A. RISK FACTORS

Ownership of our securities involves a high degree of risk. Holders of our securities should carefully consider, in addition to the historical financial statements and related notes and other information set forth in this Report, the risk factors discussed in Part I - Item 1A - Risk Factors included in our 2017 Form 10-K and the factors set forth below, all of which could materially affect our business or future results. Except with respect to the amended and restated risk factors set forth below, there have been no material changes to the risk factors disclosed in our 2017 Form 10-K. If any of the risks or uncertainties described in any of such risk factors actually occur, our business, financial condition and operating results could be adversely affected in a material way. This could cause the trading prices of our securities to decline, perhaps significantly, and you may lose part or all of your investment.

Dow has significant influence over us, which could limit your ability to influence the outcome of key transactions, including a change of control.

As of April 6, 2018, Dow owned approximately 36% of our outstanding common stock. In addition, Dow currently owns 3,000,000 of our outstanding warrants. Because of the degree of concentration of voting power (and the potential for such power to increase upon the purchase of additional stock or the exercise of warrants), your ability to elect members of our board of directors and influence our business and affairs, including any determinations with respect to mergers or other business combinations, the acquisition or disposition of assets, the incurrence of indebtedness, the issuance of any additional common stock or other equity securities, the repurchase or redemption of common stock and the payment of dividends, may be diminished.

32

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Not applicable.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

33

ITEM 6. EXHIBITS

Exhibit No.		Description
3.1	(1)	Second Amended and Restated Certificate of Incorporation, filed with the Secretary of State of the State of Delaware on July 31, 2015.
3.2	(4)	Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation.
3.3	(1)	Series A Certificate of Designation.
3.4	(2)	Amended and Restated Bylaws.
3.5	(3)	Amendment to the Amended and Restated Bylaws of AgroFresh Solutions, Inc., effective as of September 3, 2015.
3.6	(5)	Amendment to the Amended and Restated Bylaws of AgroFresh Solutions, Inc., effective as of November 2, 2017.
4.1	(1)	Specimen Common Stock Certificate.
4.2	(1)	Specimen Warrant Certificate.
31.1	*	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended.
31.2	*	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Act of 1934, as amended.
32.1	*	Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	*	XBRL Instance Document
101.SCH	*	XBRL Taxonomy Extension Schema Document
101.CAL	*	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	*	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	*	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	*	XBRL Taxonomy Extension Presentation Linkbase Document

———————————————————————————————

* Filed herewith.

(1) Incorporated by reference to an exhibit to the Current Report on Form 8-K of the Company filed with the Securities and Exchange Commission on August 6, 2015.

(2) Incorporated by reference to Annex A to the Company’s definitive proxy statement (File No. 001-36197) filed with the Securities and Exchange Commission on July 16, 2015.

(3) Incorporated by reference to an exhibit to the Current Report on Form 8-K of the Company filed with the Securities and Exchange Commission on September 10, 2015.

(4) Incorporated by reference to an exhibit to the Current Report on Form 8-K of the Company filed with the Securities and Exchange Commission on June 7, 2017.

(5) Incorporated by reference to an exhibit to the Quarterly Repor on Form 10-Q of the Company filed with the Securities and Exchange Commission on November 9, 2017.

34

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

AgroFresh Solutions, Inc.
Date:	May 10, 2018
/s/ Jordi Ferre
By:	Jordi Ferre
Title:	Chief Executive Officer
/s/ Katherine Harper
By:	Katherine Harper
Title:	Chief Financial Officer

35

EX-31.1

EXHIBIT 31.1

CERTIFICATE PURSUANT TO

RULES 13a-14(a) and 15d-14(a),

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jordi Ferre, certify that:

1. I have reviewed this quarterly report on Form 10-Q of AgroFresh Solutions, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	May 10, 2018
/s/ Jordi Ferre
By:	Jordi Ferre
Title:	Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATE PURSUANT TO

RULES 13a-14(a) and 15d-14(a),

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Katherine C. Harper, certify that:

1. I have reviewed this quarterly report on Form 10-Q of AgroFresh Solutions, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	May 10, 2018
/s/ Katherine Harper
By:	Katherine Harper
Title:	Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

AND CHIEF FINANCIAL OFFICER PURSUANT TO

18 USC. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of AgroFresh Solutions, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2018, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, Jordi Ferre, President and Chief Executive Officer, and Katherine C. Harper, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. section 1350 and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

AgroFresh Solutions, Inc.
Date:	May 10, 2018
/s/ Jordi Ferre
By:	Jordi Ferre
Title:	Chief Executive Officer
/s/ Katherine Harper
By:	Katherine Harper
Title:	Chief Financial Officer

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2018	May 03, 2018
Document and Entity Information
Entity Registrant Name	AgroFresh Solutions, Inc.
Entity Central Index Key	0001592016
Document Type	10-Q
Document Period End Date	Mar. 31, 2018
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		50,430,366
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q1

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Current Assets:
Cash and cash equivalents	$ 56,962	$ 64,533
Accounts receivable, net of allowance for doubtful accounts of $1,463 and $1,550, respectively	65,766	71,509
Inventories	20,612	24,109
Other current assets	21,840	18,684
Total current assets	165,180	178,835
Property and equipment, net	13,737	12,200
Goodwill	5,748	9,402
Intangible assets, net	746,977	757,882
Deferred income tax assets	6,606	8,198
Other assets	11,308	16,746
TOTAL ASSETS	949,556	983,263
Current Liabilities:
Accounts payable	7,337	15,014
Current portion of long-term debt	7,700	7,926
Income taxes payable	7,689	5,931
Accrued expenses and other current liabilities	43,391	65,809
Total current liabilities	66,117	94,680
Long-term debt	402,209	402,868
Other noncurrent liabilities	39,193	38,505
Deferred income tax liabilities	33,168	31,130
Total liabilities	540,687	567,183
Commitments and contingencies (see Note 17)
Stockholders’ equity:
Common stock, par value $0.0001; 400,000,000 shares authorized, 51,055,747 and 51,002,234 shares issued and 50,394,366 and 50,340,853 shares outstanding at March 31, 2018 and December 31, 2017, respectively	5	5
Preferred stock; par value $0.0001, 1 share authorized and outstanding at March 31, 2018 and December 31, 2017	0	0
Treasury stock; par value $0.0001, 661,381 shares at March 31, 2018 and December 31, 2017	(3,885)	(3,885)
Additional paid-in capital	533,524	533,015
Accumulated deficit	(121,696)	(108,729)
Accumulated other comprehensive loss	(7,613)	(12,769)
Total AgroFresh stockholders’ equity	400,335	407,637
Non-controlling Interest	8,534	8,443
Total stockholders' equity	408,869	416,080
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 949,556	$ 983,263

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Allowance for doubtful accounts	$ 1,463	$ 1,550
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, shares issued (in shares)	51,055,747	51,002,234
Common stock, shares outstanding (in shares)	50,394,366	50,340,853
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	1	1
Preferred stock, shares outstanding (in shares)	1	1
Treasury stock (in shares)	661,381	661,381
Treasury Stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Income Statement [Abstract]
Net sales	$ 38,351	$ 32,730
Cost of sales (excluding amortization, shown separately below)	10,846	5,839
Gross profit	27,505	26,891
Research and development expenses	3,069	3,297
Selling, general, and administrative expenses	16,311	16,431
Amortization of intangibles	10,939	10,445
Change in fair value of contingent consideration	138	215
Operating loss	(2,952)	(3,497)
Other income	70	40
Gain on foreign currency exchange	1,931	3,103
Interest expense, net	(8,355)	(10,293)
Loss before income taxes	(9,306)	(10,647)
Provision for income taxes	3,570	1,382
Net loss including non-controlling interests	(12,876)	(12,029)
Less: Net income attributable to non-controlling interests	91	0
Net loss attributable to AgroFresh Solutions, Inc	$ (12,967)	$ (12,029)
Net loss per share:
Basic (in dollars per share)	$ (0.26)	$ (0.24)
Diluted (in dollars per share)	$ (0.26)	$ (0.24)
Weighted average shares outstanding:
Basic (in shares)	49,741,593	49,661,469
Diluted (in shares)	49,741,593	49,661,469

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Statement of Comprehensive Income [Abstract]
Net loss	$ (12,876)	$ (12,029)
Other comprehensive income (loss):
Unrealized gain on hedging activity, net of tax $594	2,106	0
Foreign currency translation adjustments	3,050	(1,870)
Comprehensive loss	$ (7,720)	$ (13,899)

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical) $ in Thousands	3 Months Ended
	Mar. 31, 2018 USD ($)
Statement of Comprehensive Income [Abstract]
Unrealized gain on hedging activity, tax	$ 594

XML

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Treasury Stock	Additional Paid-in-Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Non-Controlling Interest
Balances - beginning at Dec. 31, 2016	$ 335,145	$ 0	$ 5	$ (3,885)	$ 475,598	$ (132,200)	$ (4,373)
Balances - beginning (in shares) at Dec. 31, 2016		1	50,698,587
Increase (Decrease) in Stockholders' Equity
Stock-based compensation	216				216
Transfer of director compensation from liability to equity					40
Issuance of restricted stock (in shares)			243,620
Comprehensive loss	(13,899)					(12,029)	(1,870)
Balances - ending at Mar. 31, 2017	321,502	$ 0	$ 5	(3,885)	475,854	(144,229)	(6,243)
Balances- ending (in shares) at Mar. 31, 2017		1	50,942,207
Balances - beginning at Dec. 31, 2017	416,080	$ 0	$ 5	(3,885)	533,015	(108,729)	(12,769)	$ 8,443
Balances - beginning (in shares) at Dec. 31, 2017		1	51,002,234
Increase (Decrease) in Stockholders' Equity
Stock-based compensation	509				509
Issuance of restricted stock (in shares)			53,513
Comprehensive loss	(7,720)					(12,967)	5,156	91
Balances - ending at Mar. 31, 2018	$ 408,869	$ 0	$ 5	$ (3,885)	$ 533,524	$ (121,696)	$ (7,613)	$ 8,534
Balances- ending (in shares) at Mar. 31, 2018		1	51,055,747

XML

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash flows from operating activities:
Net loss	$ (12,876)	$ (12,029)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	11,273	10,978
Provision for bad debts	52	180
Stock-based compensation	609	216
Pension expense	347	49
Unrealized gain on derivative instrument	0	0
Amortization of deferred financing costs	601	579
Accretion of contingent consideration	0	3,704
Increase in fair value of contingent consideration	138	215
Deferred income taxes	3,630	232
Loss on sales of property	0	81
Other	0	43
Changes in operating assets and liabilities:
Accounts receivable	5,818	9,148
Inventories	3,497	(637)
Prepaid expenses and other current assets	(430)	407
Accounts payable	(7,853)	(5,013)
Accrued expenses and other liabilities	(9,426)	(716)
Income taxes payable	1,758	(9)
Other assets and liabilities	6,279	1,408
Net cash provided by operating activities	3,417	8,836
Cash flows from investing activities:
Cash paid for property and equipment	(1,905)	(1,014)
Other investments	0	(350)
Net cash used in investing activities	(1,905)	(1,364)
Cash flows from financing activities:
Payment of Dow liabilities settlement	(10,000)	0
Repayment of long term debt	(1,407)	(1,063)
Net cash used in financing activities	(11,407)	(1,063)
Effect of exchange rate changes on cash and cash equivalents	2,324	1,137
Net (decrease) increase in cash and cash equivalents	(7,571)	7,546
Cash and cash equivalents, beginning of period	64,533	77,312
Cash and cash equivalents, end of period	56,962	84,858
Supplemental disclosures of cash flow information:
Cash paid for interest	7,242	6,085
Cash paid for income taxes	156	679
Supplemental schedule of non-cash investing and financing activities:
Accrued purchases of property and equipment	$ 0	$ 578

XML

Description of Business

3 Months Ended

Mar. 31, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Business

Description of Business

AgroFresh Solutions, Inc. (the “Company”) is a global leader in delivering innovative food preservation and waste reduction solutions for fresh produce. The Company is empowering the food industry with Smarter Freshness^TM, a range of integrated solutions designed to help growers, packers and retailers improve produce freshness and quality while reducing waste. The Company’s solutions range from pre-harvest with Harvista^TM and LandSpring^TM to its marqueeSmartFresh^TM Quality System, which includes SmartFresh^TM, AdvanStore^TM and ActiMist^TM, working together to maintain the quality of stored produce. The Company has a controlling interest in Tecnidex Fruit Protection, S.A.U. (“Tecnidex”), a leading provider of post-harvest fungicides, waxes, coatings and biocides for the citrus market. Additionally, the Company’s initial retail solution, RipeLock^TM, optimizes banana ripening for the benefit of retailers and consumers. The Company has key products registered in over 45 countries, supports approximately 3,700 direct customers and services over 25,000 storage rooms globally.

The end markets that the Company serves are seasonal and are generally aligned with the seasonal growing patterns of the Company’s customers. For those customers growing, harvesting or storing apples, the Company’s primary market, the peak season in the southern hemisphere is the first and second quarters of each year, while the peak season in the northern hemisphere is the third and fourth quarters of each year. Within each half-year period (i.e., January through June for the southern hemisphere, and July through December for the northern hemisphere) the apple growing season has historically occurred during both quarters. A variety of factors, including weather, may affect the timing of the growing, harvesting and storing patterns of the Company’s customers and therefore shift the consumption of the Company’s services and products between the first and second quarters primarily in the southern hemisphere or between the third and fourth quarters primarily in the northern hemisphere.

The Company was originally incorporated as Boulevard Acquisition Corp. (“Boulevard”), a blank check company, in Delaware on October 24, 2013, and was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. On July 31, 2015, the Company completed a Business Combination (refer to Note 3) and changed its name to AgroFresh Solutions, Inc. Prior to consummation of the Business Combination, the Company’s efforts were limited to organizational activities, its initial public offering and related financings, and the search for suitable business acquisition transactions.

XML

Basis of Presentation and Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2018

Accounting Policies [Abstract]

Basis of Presentation and Summary of Significant Accounting Policies

Basis of Presentation and Summary of Significant Accounting Policies

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and in accordance with the rules and regulations of the Securities and Exchange Commission. These financial statements include all adjustments that are necessary for a fair presentation of the Company's condensed consolidated results of operations, financial condition and cash flows for the periods shown, including normal, recurring accruals and other items. The condensed consolidated results of operations for the interim periods presented are not necessarily indicative of results for the full year.

Revenue Recognition

On January 1, 2018, the Company began to account for revenue in accordance with Accounting Standards Codification ("ASC") 606, which requires revenue recognized to represent the transfer of promised goods or services to customers at an amount that reflects the consideration which is expected to be received in exchange for those goods or services. The Company utilized the modified retrospective method of adoption to all contracts that were not completed as of January 1, 2018. Prior period results were not adjusted and continue to be reported under the accounting standards in effect for the prior period. The Company has not made any significant changes to judgments in applying ASC 606 during the three months ended March 31, 2018

Performance Obligations

The Company derives revenue from the sale of products created with proprietary technology to regulate the ripening of produce and through performing post application technical services for its customers. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account in ASC 606. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The majority of the Company’s contracts have multiple performance obligations primarily related to product application and post application services which the Company provides. For contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation using the best estimate of the standalone selling price of each distinct good or service in the contract. The method used to estimate standalone selling price is the expected cost plus a margin approach, under which the Company calculates the costs of satisfying a performance obligation and factors in an appropriate margin for that distinct good or service.

The transaction price is primarily fixed as prices are governed by the terms and conditions of the Company's contracts with customers; payment is typically made under standard terms. The Company has certain transactions that provide for variable consideration through rebate and customer loyalty programs. Depending on the program, the customer may elect to receive either a credit against its account or a cash payment. The Company recognizes an accrued provision for estimated rebates and customer loyalty program payouts at the time services are provided. The primary factors considered when estimating the provision for rebates and customer loyalty programs are the average historical experience of aggregate credits issued, the historical relationship of rebates as a percentage of total gross product sales, and the contract terms and conditions of the various rebate programs in effect at the time services are performed. The Company provides standard warranty provisions.

Performance obligations related to product application are typically satisfied at a point in time when the customer obtains control upon application. Performance obligations related to post application services are satisfied over time and revenue is recognized using the output method, as control of the service transfers to the customer over time during and after storage of the produce. The Company believes that this method provides a faithful depiction of the transfer of value over the term of the performance obligation because the level of effort in providing these services is consistent during the service period. Performance obligations related to Tecnidex sales-type leases are satisfied at the point in time that, equipment is installed at the customer site.

Disaggregation of Revenue

The Company disaggregates revenue from contracts with customers into geographic region, product and timing of transfer of goods and services. The Company determined that disaggregating revenue into these categories achieves the disclosure objective to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.

Revenues for the three months ended March 31, 2018 (in thousands)
Region	North America		EMEA		Latin America		Asia Pacific		Total Revenue
Product
1-MCP based	$	1,962	$	5,120	$	20,949	$	4,328	$	32,359
Fungicides, waxes, coatings, biocides	—		5,589		—		—		5,589
Other*	98		198		6		101		403
	$	2,060	$	10,907	$	20,955	$	4,429	$	38,351
Pattern of Revenue Recognition
Products transferred at a point in time	$	2,047	$	10,905	$	20,949	$	4,328	$	38,229
Services transferred over time	13		2		6		101		122
	$	2,060	$	10,907	$	20,955	$	4,429	$	38,351

*Other includes RipeLock, AdvanStore, technical services and sales type leases related to Tecnidex

Contract Assets and Liabilities

ASC 606 requires an entity to present a revenue contract as a contract asset when the entity performs its obligations under the contract by transferring goods or services to a customer before the customer pays consideration or before payment is due. ASC 606 also requires an entity to present a revenue contract as a contract liability in instances when a customer pays consideration, or an entity has a right to an amount of consideration that is unconditional (e.g. receivable), before the entity transfers a good or service to the customer. The following table presents changes in the Company’s contract assets and liabilities during the three months ended March 31, 2018:

Three months ended March 31, 2018	Balance at January 1, 2018		Additions		Deductions			Balance at March 31, 2018
(in thousands)
Contract assets:
Unbilled revenue	$	739	$	4,268	$	(739	)	$	4,268
Contract liabilities:
Deferred revenue	$	100	$	880	$	—		$	980

The Company recognizes contract assets in the form of unbilled revenue in instances where services are performed by the Company but not billed by period end. The Company recognizes contract liabilities in the form of deferred revenue in instances where a customer pays in advance for future services to be performed by the Company. The Company receives payments from its customers based on standard terms and conditions. No significant changes or impairment losses occurred to contract balances during the three months ended March 31, 2018. Amounts reclassified from unbilled revenue to accounts receivable for the three months ended March 31, 2018 were ($0.7 million). Amounts reclassified from deferred revenue to revenue were $0.0 million for the three months ended March 31, 2018.

Practical Expedients Elected

The Company has elected the following practical expedients in applying ASC 606 across all reportable segments:

Unsatisfied Performance Obligations. Because all of its performance obligations relate to contracts with a duration of less than one year, the Company has elected to apply the optional exemption provided in ASC 606 and therefore, is not required to disclose the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period.

Contract Costs. All incremental customer contract acquisition costs are expensed as they are incurred as the amortization period of the asset that the Company otherwise would have recognized is one year or less in duration.

Significant Financing Component.The Company does not adjust the promised amount of consideration for the effects of a significant financing component as the Company expects, at contract inception, that the period between when the entity transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.

Sales Tax Exclusion from the Transaction Price. The Company excludes from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from the customer.

Shipping and Handling Activities. The Company accounts for shipping and handling activities it performs after a customer obtains control of the good as activities to fulfill the promise to transfer the good.

Modified Retrospective Method. The Company adopted ASC 606 on January 1, 2018 utilizing the modified retrospective method, which meant the Company did not retrospectively adjust prior periods. The Company applied the modified retrospective method only to contracts that were not completed at January 1, 2018 and accounted for the aggregate effect of any contract modifications upon adoption. No cumulative adjustment to retained earnings was recorded upon adoption. The following table summarizes the amounts by which the consolidated financial statements are affected in the current reporting period by ASC 606 as compared with the guidance that was in effect before the change.

(in thousands)	As reported			ASC 606 Adjustments			Balances without adoption of ASC 606
Consolidated Balance Sheet
Liabilities
Accrued expenses and other current liabilities	$	43,391		$	(782	)	$	42,609
Equity
Accumulated deficit	$	(121,696	)	$	782		$	(120,914	)

(in thousands)	As reported			ASC 606 Adjustments		Balances without adoption of ASC 606
Consolidated Statements of Operations
Revenue
Net sales	$	38,351		$	782	$	39,133
Net loss attributable to AgroFresh Solutions, Inc	(12,967		)	$	610	$	(12,357	)

For additional information, these condensed consolidated financial statements should be read in conjunction with the consolidated and combined financial statements and notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2017.

Recently Issued Accounting Standards and Pronouncements

In August 2017, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2017-12 Targeted Improvements to Accounting for Hedging Activities. This update makes more financial and nonfinancial hedging strategies eligible for hedge accounting. It also amends the presentation and disclosure requirements and changes how companies assess effectiveness. This update will be effective for the Company for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted upon its issuance. The Company is currently assessing the impact of the future adoption of this standard on its financial statements.

In May 2017, the FASB issued ASU 2017-09, Compensation-Stock Compensation (Topic 718) Scope of Modification Accounting. ASU 2017-09 addresses the changes to the terms and conditions of share-based awards. ASU 2017-09 is effective for periods beginning after December 15, 2017 and interim periods therein on a modified retrospective basis. The Company adopted the new ASU as of January 1, 2018, and it did not have a material impact on the financial statements.

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other, which simplifies the test for goodwill impairment. The guidance is effective for the Company beginning in the first quarter of fiscal year 2020. Early adoption is permitted for interim or annual goodwill impairments tests after January 1, 2017. This standard will impact future financial statements when adopted.

In February 2016, the FASB issued ASU 2016-02, Leases. The main objective of this update is to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the impact ASU 2016-02 may have on its financial statements.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, which has been updated through several revisions and clarifications since its original issuance. The core principle of the new standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in accordance with the transfer of control over those goods and services. The new standard also requires additional disclosures intended to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue, and the related cash flows. The standard is effective for interim and annual reporting periods beginning after December 15, 2017. The Company adopted the new standard as of January 1, 2018, using the modified retrospective approach to all contracts that were not completed as of January 1, 2018. Prior period results were not adjusted and continue to be reported under the accounting standards in effect for the prior period. See the Revenue Recognition subsection above in this Note 2 for further details on the impact to the Company’s financial statements upon adoption and practical expedients elected.

XML

Business Combinations

3 Months Ended

Mar. 31, 2018

Business Combinations [Abstract]

Business Combinations

Business Combinations

Business Combination with Dow

On July 31, 2015 (the "Closing Date"), the Company consummated a business combination (the “Business Combination”) pursuant to the Stock Purchase Agreement, dated April 30, 2015 (the “Purchase Agreement”), by and between the Company and The Dow Chemical Company ("Dow") providing for the acquisition by the Company of the AgroFresh Business from Dow, resulting in AgroFresh Inc. becoming a wholly-owned, indirect subsidiary of the Company. Pursuant to the Purchase Agreement, the Company paid the following consideration to Rohm and Haas Company (“R&H”), a subsidiary of Dow: (i) 17.5 million shares of common stock (the “Stock Consideration”) and (ii) $635 million in cash (the “Cash Consideration”).

On April 4, 2017, the Company entered into an agreement (the “Amendment Agreement”) with Dow, R&H, Boulevard Acquisition Sponsor, LLC (the “Sponsor”), AgroFresh Inc., Avenue Capital Management II, L.P. (“Avenue”) and, solely as to certain sections of the Amendment Agreement, Joel Citron, Darren Thompson and Robert J. Campbell (collectively, the “Founding Holders”), Marc Lasry and Stephen Trevor. Pursuant to the Amendment Agreement and certain related agreements entered into on the same date (as described below), among other things, the Company and Dow agreed to modify certain obligations of the Company pursuant to (i) the Purchase Agreement, (ii) the Tax Receivables Agreement, dated July 31, 2015 (the “Tax Receivables Agreement”), among the Company, Dow, R&H and AgroFresh Inc., and (iii) the Warrant Purchase Agreement, dated July 31, 2015 (the “Warrant Purchase Agreement”), among the Company, Dow, R&H and the Sponsor. Mr. Campbell is a member of the Company's board of directors, each of Mr. Lasry and Mr. Trevor was a member of the Company’s board of directors at the time the Amendment Agreement was entered into, Dow is a significant stockholder of the Company and the Sponsor was a significant stockholder of the Company at the time the Amendment Agreement was entered into.

Amendment Agreement

Pursuant to the Amendment Agreement, the Company agreed to pay Dow the aggregate amount of $20.0 million, of which $10.0 million was paid on April 4, 2017 and the remaining $10.0 million was paid on January 31, 2018, in full satisfaction of the Company’s obligations with respect to (i) the working capital adjustment under the Purchase Agreement, (ii) certain transfer and value added tax reimbursement obligations under the Purchase Agreement, and (iii) the amount payable to Dow pursuant to the Tax Receivables Agreement on account of the 2015 tax year. During the three the months ended March 31, 2018 these liabilities were extinguished.

First Amendment to Tax Receivables Agreement

The Company, Dow, R&H and AgroFresh Inc. entered into a First Amendment to the Tax Receivables Agreement (the “TRA Amendment”). The TRA Amendment reduces, from 85% to 50%, the percentage that the Company is required to pay to Dow pursuant to the Tax Receivables Agreement of the annual tax savings, if any, in U.S. federal, state and local income tax or franchise tax that the Company actually realizes as a result of the increase in tax basis of the AgroFresh assets resulting from a Section 338(h)(10) election that the Company and Dow made in connection with the Business Combination.

Stock Buyback Agreement

The Company and Dow entered into a letter agreement (the “Stock Buyback Agreement”), pursuant to which Dow agreed to use its reasonable best efforts to purchase up to 5,070,358 shares of the Company’s common stock in the open market (representing approximately 10% of the total number of shares of the Company’s common stock then outstanding), over a period of up to 18 months.

Termination of Warrant Purchase Agreement

The Company, Dow, R&H and the Sponsor entered into a letter agreement, pursuant to which the Warrant Purchase Agreement was terminated effective immediately.

As a result of the Amendment Agreement, the TRA Amendment and the termination of the Warrant Purchase Agreement, the Company recorded a reduction of liabilities of $95.1 million net of deferred income taxes of $40.0 million. The net impact of $55.1 million has been recorded to additional paid-in capital as the agreements were with related parties and the transaction has been treated as a capital transaction.

Acquisition of Tecnidex

On November 7, 2017, the Company entered into a definitive agreement to acquire a controlling-interest in Tecnidex Fruit Protection, S.A.U. ("Tecnidex"). The transaction was closed on December 1, 2017. Tecnidex, a privately-held international company, is a leading provider of post-harvest fungicides, waxes, coatings, and biocides for the citrus market, with clients in 18 countries. For over 35 years, Tecnidex has been helping fruit and vegetable producers offer clean, safe and high-quality products to their regional clients. The acquisition was accounted for as a purchase in accordance with ASC 805, Business Combination.

At the effective date of the acquisition, the Company agreed to pay holders of Tecnidex estimated $25.0 million in cash for 75% of the outstanding capital stock, of which $20.0 million was paid on December 1, 2017. In the second quarter of 2018 the price is expected to be finalized and paid based on working capital, net debt and other adjustments.

In accordance with the acquisition method of accounting, the Company is allocating the purchase price to the estimated fair values of the identifiable assets acquired and liabilities assumed, with any excess allocated to goodwill. The allocation of the purchase price accounting is preliminary as the Company is still in the process of valuing the assets acquired and liabilities assumed; therefore the allocation of the acquisition consideration is subject to change.

The preliminary assessment of fair value of the contingent consideration payments on the acquisition date was approximately $0.7 million and was estimated by applying a probability-based income approach utilizing an appropriate discount rate. This estimation was based on significant inputs that are not observable in the market, referred to as Level 3 inputs. During the three months ended March 31, 2018 there was an adjustment made to consideration payable to holders of Tecnidex which resulted in a measurement period adjustment of $3.7 million to the purchase price allocation.

XML

Related Party Transactions

3 Months Ended

Mar. 31, 2018

Related Party Transactions [Abstract]

Related Party Transactions

Related Party Transactions

The Company is a party to ongoing agreements with Dow, a related party, including, but not limited to, operating-related agreements for certain transition services and seconded employees. In addition, during the three months ended March 31, 2018, the Company paid $0.7 million to Dow in order to terminate the provision of IT services provided by Dow.

The Company incurred expenses for such services for the three months ended March 31, 2018 and March 31, 2017 as follows:

(amounts in thousands)	Three Months Ended March 31, 2018		Three Months Ended March 31, 2017
Amortization of prepayment related to set-up of transition services	$	—	$	207
Ongoing costs of transition services agreement	84		743
Rent expense	—		248
Other expenses	295		95
Total incurred expenses	$	379	$	1,293

As of March 31, 2018 and March 31, 2017, the Company had an outstanding payable to Dow of $0.0 million and $0.3 million, respectively.

Refer to Note 3 regarding the contingent consideration owed to Dow as part of the Business Combination.

In addition, during 2016, the Company made a minority investment in RipeLocker, LLC ("RipeLocker"), a company led by George Lobisser, a director of AgroFresh. On November 29, 2016, the Company entered into a Mutual Services Agreement (the “Services Agreement”) with George Lobisser and RipeLocker. Pursuant to the Services Agreement, (i) the Company agreed to provide RipeLocker with technical support, in the form of access to the Company’s research and development personnel for a specified number of hours for purposes of providing advice and input relating to RipeLocker’s products and services, and (ii) Mr. Lobisser agreed to provide consulting services to the Company as may be reasonably requested by the Company from time to time. The Services Agreement provided for Mr. Lobisser to receive a consulting fee of $5,000 per full day for time spent performing consulting services under the Services Agreement (pro-rated for any partial day), plus reimbursement for out-of-pocket expenses, provided that for each hour of technical support provided by the Company to RipeLocker, Mr. Lobisser agreed to provide one-half hour of consulting services for no consideration. In February 2017, the Company and Mr. Lobisser agreed to substantially curtail any mutual consulting services to be provided under the Services Agreement, and that any further services would be provided at no charge. For the three months ended March 31, 2018, there were no material amounts paid and as of March 31, 2018, there were no material amounts owed to RipeLocker or Mr. Lobisser for consulting services.

XML

Inventories

3 Months Ended

Mar. 31, 2018

Inventory Disclosure [Abstract]

Inventories

Inventories

Inventories at March 31, 2018 and December 31, 2017 consisted of the following:

(in thousands)	March 31, 2018		December 31, 2017
Raw material	$	1,967	$	2,148
Work-in-process	3,456		6,585
Finished goods	14,476		14,647
Supplies	713		729
Total inventories	$	20,612	$	24,109

XML

Other Current Assets

3 Months Ended

Mar. 31, 2018

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Other Current Assets

Other Current Assets

The Company's other current assets at March 31, 2018 and December 31, 2017 consisted of the following:

(in thousands)	March 31, 2018		December 31, 2017
VAT receivable	$	14,454	$	14,088
Prepaid income tax asset	2,289		2,314
Other	5,097		2,282
Total other current assets	$	21,840	$	18,684

XML

Property and Equipment

3 Months Ended

Mar. 31, 2018

Property, Plant and Equipment [Abstract]

Property and Equipment

Property and Equipment

Property and equipment at March 31, 2018 and December 31, 2017 consisted of the following:

(in thousands, except for useful life data)	Useful life (years)	March 31, 2018			December 31, 2017
Leasehold improvements	7-20	$	3,015		$	2,976
Machinery & equipment	1-12	7,799			7,853
Furniture	1-12	1,707			1,698
Construction in progress		3,987			2,075
		16,508			14,602
Less: accumulated depreciation		(2,771		)	(2,402		)
Total property and equipment, net		$	13,737		$	12,200

Depreciation expense for the three months ended March 31, 2018 and March 31, 2017 was $0.4 million and $0.3 million, respectively. Depreciation expense is recorded in cost of sales, selling, general and administrative expense and research and development expense in the condensed consolidated statements of operations.

XML

Goodwill and Intangible Assets

3 Months Ended

Mar. 31, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

Goodwill and Intangible Assets

Changes in the carrying amount of goodwill for the three months ended March 31, 2018 are as follows:

(in thousands)	Goodwill
Balance as of December 31, 2017	$	9,402
Measurement period adjustment	(3,654		)
Balance as of March 31, 2018	$	5,748

See note 3 for a description of the measurement period adjustment.

The Company’s intangible assets at March 31, 2018 and December 31, 2017 consisted of the following:

	March 31, 2018							December 31, 2017
(in thousands)	Gross Carrying Amount		Accumulated Amortization			Net		Gross Carrying Amount		Accumulated Amortization			Net
Other intangible assets:
Developed technology	$	759,374	$	(105,089	)	$	654,285	$	759,374	$	(94,886	)	$	664,488
In-process research and development	39,000		(3,431		)	35,569		39,000		(2,889		)	36,111
Trade name	29,816		—			29,816		29,816		—			29,816
Service provider network	2,000		—			2,000		2,000		—			2,000
Customer relationships	20,306		(889		)	19,417		20,306		(806		)	19,500
Software	1,274		(477		)	797		1,274		(404		)	870
Software not yet placed in service	5,022		—			5,022		5,022					5,022
Other	100		(29		)	71		100		(25		)	75
Total intangible assets	$	856,892	$	(109,915	)	$	746,977	$	856,892	$	(99,010	)	$	757,882

At March 31, 2018, the weighted-average amortization period remaining for the finite-lived intangible assets was 17.1 years. At March 31, 2018, the weighted-average amortization periods remaining for developed technology, customer relationships, in-process R&D, software and other was 17.0, 21.3, 16.5, 2.6, and 4.3 years, respectively.

Estimated annual amortization expense for finite-lived intangible assets, excluding amounts in Work in Progress, subsequent to March 31, 2018 is as follows:

(in thousands)	Amount
2018 (remaining)	$	32,753
2019	43,970
2020	43,951
2021	43,814
2022	43,691
Thereafter	501,960
Total	$	710,139

XML

Accrued and Other Current Liabilities

3 Months Ended

Mar. 31, 2018

Payables and Accruals [Abstract]

Accrued and Other Current Liabilities

Accrued and Other Current Liabilities

The Company’s accrued and other current liabilities at March 31, 2018 and December 31, 2017 consisted of the following:

(in thousands)	March 31, 2018		December 31, 2017
Tax amortization benefit contingency	$	11,820	$	11,820
Additional consideration due seller	831		693
Dow settlement liability	—		10,000
Accrued compensation and benefits	7,252		8,932
Accrued rebates payable	5,045		5,027
Insurance premium financing payable	321		639
Severance	395		113
Deferred revenue	980		100
Other notes payable	1,401		5,056
Accrued taxes	8,710		7,848
Accrued interest	6,527		6,321
Other	109		9,260
Total accrued and other current liabilities	$	43,391	$	65,809

XML

Debt

3 Months Ended

Mar. 31, 2018

Debt Disclosure [Abstract]

Debt

Debt

The Company’s debt, net of unamortized discounts and deferred financing fees, at March 31, 2018 and December 31, 2017 consisted of the following:

(in thousands)	March 31, 2018		December 31, 2017
Total Term Loan outstanding	$	406,568	$	407,109
Tecnidex loan outstanding	3,341		3,685
Less: Amounts due within one year	7,700		7,926
Total long-term debt due after one year	$	402,209	$	402,868

At March 31, 2018, the Company evaluated the amount recorded under the Term Loan (defined below) and determined that the fair value was approximately $417.5 million. The fair value of the debt is based on quoted inactive market prices and is therefore classified as Level 2 within the valuation hierarchy.

The Term Loan is presented net of deferred issuance costs, which are amortized using the effective interest method over the term of the Term Loan. Gross deferred issuance costs at the inception of the Term Loan were $12.9 million and as of March 31, 2018 there were $7.7 million of unamortized deferred issuance costs.

Scheduled principal repayments of debt subsequent to March 31, 2018 are as follows:

(in thousands)	Amount
2018 (remaining)	$	6,637
2019	5,204
2020	4,250
2021	401,625
Total	$	417,716

Credit Facility

On July 31, 2015, in connection with the consummation of the Business Combination, AgroFresh Inc. as the borrower and its parent, AF Solutions Holdings LLC (“AF Solutions Holdings”), a wholly-owned subsidiary of the Company, as the guarantor, entered into a Credit Agreement with Bank of Montreal, as administrative agent (the “Credit Facility”). The Credit Facility consists of a $425 million term loan (the “Term Loan”), with an amortization equal to 1.00% per year, and a $25 million revolving loan facility (the “Revolving Loan”). The Revolving Loan includes a $10 million letter-of-credit sub-facility, issuances against which reduce the available capacity for borrowing. As of March 31, 2018, the Company has issued $0.5 million of letters of credit, against which no funds have been drawn. The Term Loan has a scheduled maturity date of July 31, 2021, and the Revolving Loan has a scheduled maturity date of July 31, 2019. The interest rates on borrowings under the facilities are either the alternate base rate plus 3.75% or LIBOR plus 4.75% per annum, with a 1.00% LIBOR floor (with step-downs in respect of borrowings under the Revolving Loan dependent upon the achievement of certain financial ratios). The obligations under the Credit Facility are secured by liens on substantially all of the assets of (a) AgroFresh Inc. and its direct wholly-owned domestic subsidiaries, and (b) AF Solutions Holdings, including the common stock of AgroFresh Inc.

The net proceeds of the Term Loan were used to fund a portion of the purchase price payable to R&H in connection with the Business Combination. Amounts available under the Revolving Loan may also be used for working capital, general corporate purposes, and other uses, all as more fully set forth in the Credit Agreement. At March 31, 2018, there was $414.3 million outstanding under the Term Loan and no balance outstanding under the Revolving Loan.

As of the Closing Date, the Company incurred approximately $12.9 million in debt issuance costs related to the Term Loan and $1.3 million in costs related to the Revolving Loan. The debt issuance costs associated with the Term Loan were capitalized against the principal balance of the debt, and the Revolving Loan costs were capitalized in Other Assets. All issuance costs will be accreted through interest expense for the duration of each respective debt facility. The interest expense related to the amortization of the debt issuance costs during the three months ended March 31, 2018 was approximately $0.6 million.

On November 18, 2015, the Credit Facility was amended. An existing provision in the credit agreement permitted the Company, subject to an overall cap of $12.0 million per fiscal year and certain other conditions, to pay dividends to the Company’s public stockholders and to redeem or repurchase, through July 31, 2016, the Company’s outstanding warrants for an aggregate purchase price of up to $10.0 million. The amendment expanded the scope of this provision to also permit the repurchase of shares of the Company’s outstanding common stock or other equity securities (subject to the same overall cap and other conditions).

Certain restrictive covenants are contained in the Credit Facility, which the Company was in compliance with as of March 31, 2018, other than certain covenants that would apply only to the extent  the Company draws against the Revolving Loan and has an outstanding balance at the end of a calendar quarter-end. There were no outstanding draws against the Revolving Loan as of March 31, 2018.

Beginning with the year ended December 31, 2016, the Company is required to prepay Term Loan Borrowings and Incremental Term Loan Borrowings in an aggregate amount equal to 50% of the Excess Cash Flow for the fiscal year; provided that such amount of the Excess Cash Flow in any fiscal year shall be reduced by (i) the aggregate amount of prepayments of Term Loans and Incremental Term Loans made, (ii) to the extent accompanied by permanent reductions of Revolving Commitments, the aggregate amount of prepayments of Revolving Loans (other than prepayments financed with the proceeds of Indebtedness), and (iii) repaid borrowings of Revolving Loans made on the Effective Date to account for any additional original issue discount or upfront fees that are implemented pursuant to the Fee Letter provided further that, prepayments of Term Loan Borrowings and Incremental Term Loan Borrowings shall only be required if 50% of the Excess Cash Flow for such fiscal year exceeds $5,000,000. There are no amounts due under this provision as of March 31, 2018.

XML

Other Noncurrent Liabilities

3 Months Ended

Mar. 31, 2018

Liabilities, Other than Long-term Debt, Noncurrent [Abstract]

Other Noncurrent Liabilities

Other Noncurrent Liabilities

The Company’s other noncurrent liabilities at March 31, 2018 and December 31, 2017 consisted of the following:

(in thousands)	March 31, 2018		December 31, 2017
Tax amortization benefit contingency	$	32,670	$	31,562
Other	6,523		6,943
Total other noncurrent liabilities	$	39,193	$	38,505

XML

Severance

3 Months Ended

Mar. 31, 2018

Compensation Related Costs [Abstract]

Severance

Severance

The Company expensed $0.3 million and $0.0 million for severance for the three months ended March 31, 2018 and March 31, 2017, respectively. This amount, which does not include stock compensation expense, was recorded in selling, general and administrative expense in the condensed consolidated statements of operations. As of March 31, 2018, the Company had $0.5 million of severance liability, of which $0.4 million will be paid out over the next year.

XML

Stockholders' Equity

3 Months Ended

Mar. 31, 2018

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stockholders’ Equity

The authorized common stock of the Company consists of 400,000,000 shares with a par value of $0.0001 per share. Holders of the Company’s common stock are entitled to one vote for each share of common stock. As of March 31, 2018, there were 50,394,366 shares of common stock outstanding. As of March 31, 2018, there were warrants to purchase 15,983,072 shares of the Company’s common stock outstanding at a strike price of $11.50. Of the 15,983,072 warrants, 9,823,072 were issued as part of the units sold in the Company's initial public offering in February 2014 (1,201,928 warrants were subsequently repurchased during 2015) and 6,160,000 warrants were sold in a private placement at the time of such public offering.

On November 18, 2015, the Company announced that its board of directors had authorized a stock repurchase program (the “Repurchase Program”). The Repurchase Program authorized the Company to repurchase in the aggregate up to $10 million of the Company’s publicly-traded shares of common stock. The Repurchase Program was in effect for a period of one year, until November 17, 2016. Under the Repurchase Program, the Company repurchased 661,381 shares of its common stock for $3.9 million, which shares are classified as treasury stock on the condensed consolidated balance sheet.

In connection with and as a condition to the consummation of the Business Combination, the Company issued R&H one share of Series A Preferred Stock. R&H, voting as a separate class, is entitled to appoint one director to the Company’s board of directors for so long as R&H beneficially holds 10% or more of the aggregate amount of the outstanding shares of common stock and non-voting common stock of the Company. The Series A Preferred Stock has no other rights.

Simultaneously with the consummation of the Business Combination, the Company issued 4,878,048 shares of common stock at a price of $10.25 per share in a private placement to raise an aggregate of $50 million of additional equity.

XML

Stock-based Compensation

3 Months Ended

Mar. 31, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-based Compensation

Stock-based Compensation

Stock compensation expense for both equity-classified and liability-classified awards for the three months ended March 31, 2018 and March 31, 2017 was $0.6 million and $0.2 million, respectively. Stock compensation expense is recognized in cost of goods sold, selling, general and administrative expenses, and research and development expenses. At March 31, 2018, there was $3.5 million of unrecognized compensation cost relating to outstanding unvested equity instruments expected to be recognized over the weighted average period of 1.7 years.

On March 29, 2018, the Company granted the following share-based awards to members of management employed in the United States. These awards will be settled in shares of the Company's common stock and are equity-classified. The grant date fair value of these awards will be recognized on a straight-line basis over the vesting period. The performance-based restricted stock units each have a performance period that ends on December 31, 2020 and the other awards vest ratably on the first, second, and third anniversaries of the grant date.

Performance-based restricted stock units	195,650
Time-based restricted stock	149,700
Options	134,250
Total	479,600

On March 29, 2018, the Company also granted the following share-based awards to members of management employed in countries outside of the United States. These awards will be settled in cash and are liability-classified. Therefore, the fair value of these liability-classified awards will be re-measured on each balance sheet date. The performance-based phantom shares each have a performance period that ends on December 31, 2020 and the other awards vest ratably on the first, second, and third anniversaries of the grant date.

Performance-based phantom shares	24,450
Service-based phantom shares	41,750
Stock appreciation rights	2,800
Total	69,000

The performance-based restricted stock units and phantom shares were valued with a Monte Carlo simulation model using the assumptions in the table below. Based on these assumptions, the grant date fair value of the performance-based restricted stock units and phantom shares was estimated to be $7.28 per share.

Volatility	69.9		%
Risk-free interest rate	2.39		%
Dividend yield	0.00		%
Grant date stock price	$	7.35
Performance period	3 years

The stock options and stock appreciation rights were valued with a Black-Scholes option pricing model using the assumptions in the table below. Since the Company has limited historical volatility information available, the expected volatility was based on actual volatility for comparable public companies projected over the expected term of the Options and the actual volatility for the Company since the Business Combination. The risk-free interest rate was based on the U.S. Treasury yield curve at the time of the grant over the expected term of the Options. The expected life was estimated using the simplified method. Based on these assumptions, the grant-date fair value of the stock options and stock appreciation rights was estimated to be $3.57.

Volatility	48.80		%
Risk-free interest rate	2.56		%
Dividend yield	0.00		%
Grant date stock price	$	7.35
Expected term	6 years

The fair value of the time-based restricted stock and the service-based phantom shares is equal to the closing price of the Company’s common stock on the grant date of the awards.

XML

Earnings Per Share

3 Months Ended

Mar. 31, 2018

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

Basic loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding for the period. Due to the loss in the quarter, dilutive loss per share is the same as basic loss per share as the adjustment for the assumed issuance of all potentially dilutive share-based awards, including stock options, restricted stock and warrants would be anti-dilutive.

The following is a reconciliation of the weighted-average common shares outstanding used for the computation of basic and diluted net loss per common share:

	Three Months Ended March 31, 2018	Three Months Ended March 31, 2017
Basic weighted-average common shares outstanding	49,741,593	49,661,469
Effect of dilutive options, performance stock units and restricted stock	—	—
Dilute weighted-average shares outstanding	49,741,593	49,661,469

Securities that could potentially be dilutive are excluded from the computation of diluted earnings per share when a loss from continuing operations exists or when the exercise price exceeds the average closing price of the Company's common stock during the period, because their inclusion would result in an anti-dilutive effect on per share amounts.

The following represents amounts that could potentially dilute basic earnings per share in the future:

(in thousands, except share data)	Three Months Ended March 31, 2018	Three Months Ended March 31, 2017
Stock-based compensation awards(1):
Stock options	63,019	926,898
Restricted stock to non-directors	610,642	797,401
Restricted stock to directors	122,929	78,754
Warrants:
Private placement warrants	6,160,000	6,160,000
Public warrants	9,823,072	9,823,072

———————————————————————————————

(1) SARs and Phantom Shares are payable in cash so will therefore have no impact on number of shares

Warrants and options are considered anti-dilutive and excluded when the exercise price exceeds the average market value of the Company’s common stock price during the applicable period. Performance share units are considered anti-dilutive if the performance targets upon which the issuance of the shares is contingent have not been achieved and the respective performance period has not been completed as of the end of the current period.

XML

Income Taxes

3 Months Ended

Mar. 31, 2018

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

The provision for income taxes consists of provisions for federal, state, and foreign incomes taxes. The effective tax rates for the periods ended March 31, 2018, and March 31, 2017, reflect the Company’s expected tax rate on reported income from continuing operations before income tax and tax adjustments. The Company operates in a global environment with significant operations in the U.S. and various other jurisdictions outside the U.S. Accordingly, the consolidated income tax rate is a composite rate reflecting the Company’s earnings and the applicable tax rates in the various jurisdictions where the Company operates.

On December 22, 2017, the Tax Cuts and Jobs Act (“TCJA”) was enacted in the U.S. The TCJA represents sweeping changes in U.S. tax law. Among other changes in tax law, the TCJA permanently reduced the U.S. corporate income tax rate to 21% beginning in 2018; imposed a one-time repatriation tax on deferred foreign earnings; established a participation exemption system by allowing a 100% dividends received deduction on qualifying dividends paid by foreign subsidiaries; limited deductions for net interest expense; and expanded the U.S. taxation of foreign earned income to include “global intangible low-taxed income” (“GILTI”).

As permitted by SAB No. 118, the tax benefit recorded in the fourth quarter of 2017 due to the enactment of the TCJA was considered “provisional”, based on reasonable estimates. The Company is continuing to collect and analyze detailed information about the earnings and profits of its non-U.S. subsidiaries, the related taxes paid, the amounts which could be repatriated, the foreign taxes which may be incurred on repatriation, and the associated impact of these items under the TCJA. The Company may record adjustments to refine those estimates during the measurement period, as additional analysis is completed. No adjustments were recorded during the first fiscal quarter of 2018.

The TCJA transitions the U.S. from a worldwide tax system to a territorial tax system. Under previous law, companies could indefinitely defer U.S. income taxation on unremitted foreign earnings. The TCJA imposes a one-time repatriation tax on deferred foreign earnings of 15.5% for liquid assets and 8% for illiquid assets, payable in defined increments over eight years. As a result of this requirement, the Company recognized provisional tax expense of $0.5 million in 2017, and provisionally expects to pay $0.3 million, net of estimated applicable foreign tax credits, and after utilization of FTC Credit carryforwards. These previously deferred foreign earnings may now be repatriated to the U.S. without additional U.S. federal taxation. However, any such repatriation could incur withholding and other foreign taxes in the source and intervening foreign jurisdictions, and certain U.S. state taxes. The Company continues to not recognize any U.S. income or foreign withholding taxes for the differences between the financial reporting and tax basis of the investments in foreign subsidiaries that are indefinitely reinvested outside the U.S. This amount may be recognized upon a sale or liquidation.

The Company's effective tax rate for the three months ended March 31, 2018 was (38.4)%, compared to the effective tax rate of (13.0)% for the three months ended March 31, 2017.

The effective tax rate for the three months ended March 31, 2018 differs from the U.S. statutory tax rate of 21%, due to unbenefited losses and certain provisions of the TCJA. The unbenefited losses related to the elimination of intercompany profit in inventory. The provisions of the TCJA are interrelated and the impact of any specific provision cannot be isolated. The Company operates at a pre-tax loss and the reduction in the federal tax rate to 21% reduces the tax benefit recorded. In addition, the inclusion of GILTI income and the limitation and deductibility of interest expense increased the effective tax rate. The Company has elected to account for GILTI tax in the period in which it is incurred, and therefore did not provide any deferred taxes in the consolidated financial statements at December 31, 2017.

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2018

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

The Company is currently involved in various claims and legal actions that arise in the ordinary course of business. The Company has recorded reserves for loss contingencies based on the specific circumstances of each case. Such reserves are recorded when it is probable that a loss has been incurred as of the balance sheet date and can be reasonably estimated. Although the results of litigation and claims can never be predicted with certainty, the Company does not believe that the ultimate resolution of these actions will have a material adverse effect on the Company’s business, financial condition or results of operations.

Purchase Commitments

The Company has various purchasing contracts for contract manufacturing and research and development services which are based on the requirements of the business. Generally, the contracts are at prices not in excess of current market prices and do not commit the business to obligations outside the normal customary terms for similar contracts.

XML

Fair Value Measurements

3 Months Ended

Mar. 31, 2018

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements

Liabilities Measured at Fair Value on a Recurring Basis

The following table presents the fair value of the Company’s financial instrument liability/(asset) that are measured at fair value on a recurring basis as of March 31, 2018:

(in thousands)	Level 1		Level 2			Level 3		Total
Tax amortization benefit contingency(1)	$	—	$	—		$	44,490	$	44,490
Contingent consideration(2)	—		—			831		831
Interest rate contract (3)	—		(2,244		)	—		(2,244		)
Stock appreciation rights(4)	—		—			176		176
Phantom shares(5)	—		—			286		286
Total	$	—	$	(2,244	)	$	45,783	$	43,539

The following table presents the fair value of the Company’s financial instruments that are measured at fair value on a recurring basis as of December 31, 2017:

(in thousands)	Level 1		Level 2		Level 3		Total
Tax amortization benefit contingency(1)	$	—	$	—	$	43,382	$	43,382
Contingent consideration(2)	—		—		693		693
Interest rate contract (3)	—		456		—		456
Stock appreciation rights(4)	—		—		268		268
Phantom shares(5)	—		—		186		186
Total	$	—	$	456	$	44,529	$	44,985

———————————————————————————————

(1) The fair value of the tax amortization benefit contingency is measured using an income approach based on the Company’s best estimate of the undiscounted cash payments to be made, with the current portion tax effected at 35.3% and the non-current portion tax effected at 21.5% due to the Tax Cuts and Job Act (TCJA) of December 2017 enacted in the U.S and discounted to present value utilizing an appropriate market discount rate. Per the April 4, 2017 Amendment Agreement, payments due to Dow under the Tax Receivable Agreement was reduced from 85% to 50% of the applicable tax savings realized by the Company. The valuation technique used did not change during the three months ended March 31, 2018.

(2) The fair value of the contingent consideration related to the Tecnidex acquisition.

(3) The derivative assets and liabilities relate to an interest rate derivative that is measured at fair value using observable market inputs such as interest rates, our own credit risks as well as an evaluation of the counterparts' credit risks. The fair value for the three months ended March 31, 2018 resulted in an asset balance while the three months ended December 31, 2017 is in a liability balance.

(4) The fair value of the stock appreciation rights was measured using a Black Scholes pricing model during the three months ended March 31, 2018. The valuation technique used did not change during the three months ended March 31, 2018.

(5) The fair value of phantom shares are based on the fair value of the Company's common stock. The valuation technique used did not change during the three months ended March 31, 2018.

There were no transfers between Level 1 and Level 2 and no transfers out of Level 3 of the fair value hierarchy during the three months ended March 31, 2018.

At March 31, 2018, the Company evaluated the amount recorded under the Term Loan and determined that the fair value was approximately $417.5 million. The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable approximate fair value.

Changes in Financial Instruments Measured at Level 3 Fair Value on a Recurring Basis

The following table presents the changes during the period presented in our Level 3 financial instrument liability/(asset) that are measured at fair value on a recurring basis.

(in thousands)	Tax amortization benefit contingency		Contingent consideration related to acquisition		Interest rate contract			Stock appreciation rights			Phantom shares		Total
Balance, December 31, 2017	$	43,382	$	693	$	456		$	268		$	186	$	44,985
Accretion	1,108		—		—			—			—		1,108
Stock compensation expense	—		—		—			(92		)	100		8
Mark-to-market adjustment	—		138		(2,700		)	—			—		(2,562		)
Balance, March 31, 2018	$	44,490	$	831	$	(2,244	)	$	176		$	286	$	43,539

XML

Basis of Presentation and Summary of Significant Accounting Policies (Policy)

3 Months Ended

Mar. 31, 2018

Accounting Policies [Abstract]

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and in accordance with the rules and regulations of the Securities and Exchange Commission. These financial statements include all adjustments that are necessary for a fair presentation of the Company's condensed consolidated results of operations, financial condition and cash flows for the periods shown, including normal, recurring accruals and other items. The condensed consolidated results of operations for the interim periods presented are not necessarily indicative of results for the full year.

Revenue Recognition

Revenue Recognition

On January 1, 2018, the Company began to account for revenue in accordance with Accounting Standards Codification ("ASC") 606, which requires revenue recognized to represent the transfer of promised goods or services to customers at an amount that reflects the consideration which is expected to be received in exchange for those goods or services. The Company utilized the modified retrospective method of adoption to all contracts that were not completed as of January 1, 2018. Prior period results were not adjusted and continue to be reported under the accounting standards in effect for the prior period. The Company has not made any significant changes to judgments in applying ASC 606 during the three months ended March 31, 2018

Performance Obligations

The Company derives revenue from the sale of products created with proprietary technology to regulate the ripening of produce and through performing post application technical services for its customers. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account in ASC 606. A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The majority of the Company’s contracts have multiple performance obligations primarily related to product application and post application services which the Company provides. For contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation using the best estimate of the standalone selling price of each distinct good or service in the contract. The method used to estimate standalone selling price is the expected cost plus a margin approach, under which the Company calculates the costs of satisfying a performance obligation and factors in an appropriate margin for that distinct good or service.

The transaction price is primarily fixed as prices are governed by the terms and conditions of the Company's contracts with customers; payment is typically made under standard terms. The Company has certain transactions that provide for variable consideration through rebate and customer loyalty programs. Depending on the program, the customer may elect to receive either a credit against its account or a cash payment. The Company recognizes an accrued provision for estimated rebates and customer loyalty program payouts at the time services are provided. The primary factors considered when estimating the provision for rebates and customer loyalty programs are the average historical experience of aggregate credits issued, the historical relationship of rebates as a percentage of total gross product sales, and the contract terms and conditions of the various rebate programs in effect at the time services are performed. The Company provides standard warranty provisions.

Performance obligations related to product application are typically satisfied at a point in time when the customer obtains control upon application. Performance obligations related to post application services are satisfied over time and revenue is recognized using the output method, as control of the service transfers to the customer over time during and after storage of the produce. The Company believes that this method provides a faithful depiction of the transfer of value over the term of the performance obligation because the level of effort in providing these services is consistent during the service period. Performance obligations related to Tecnidex sales-type leases are satisfied at the point in time that, equipment is installed at the customer site.

The Company recognizes contract assets in the form of unbilled revenue in instances where services are performed by the Company but not billed by period end. The Company recognizes contract liabilities in the form of deferred revenue in instances where a customer pays in advance for future services to be performed by the Company. The Company receives payments from its customers based on standard terms and conditions. No significant changes or impairment losses occurred to contract balances during the three months ended March 31, 2018. Amounts reclassified from unbilled revenue to accounts receivable for the three months ended March 31, 2018 were ($0.7 million). Amounts reclassified from deferred revenue to revenue were $0.0 million for the three months ended March 31, 2018.

Practical Expedients Elected

The Company has elected the following practical expedients in applying ASC 606 across all reportable segments:

Unsatisfied Performance Obligations. Because all of its performance obligations relate to contracts with a duration of less than one year, the Company has elected to apply the optional exemption provided in ASC 606 and therefore, is not required to disclose the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period.

Contract Costs. All incremental customer contract acquisition costs are expensed as they are incurred as the amortization period of the asset that the Company otherwise would have recognized is one year or less in duration.

Significant Financing Component.The Company does not adjust the promised amount of consideration for the effects of a significant financing component as the Company expects, at contract inception, that the period between when the entity transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.

Sales Tax Exclusion from the Transaction Price. The Company excludes from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from the customer.

Shipping and Handling Activities. The Company accounts for shipping and handling activities it performs after a customer obtains control of the good as activities to fulfill the promise to transfer the good.

Modified Retrospective Method. The Company adopted ASC 606 on January 1, 2018 utilizing the modified retrospective method, which meant the Company did not retrospectively adjust prior periods. The Company applied the modified retrospective method only to contracts that were not completed at January 1, 2018 and accounted for the aggregate effect of any contract modifications upon adoption. No cumulative adjustment to retained earnings was recorded upon adoption.

Recently Issued Accounting Standards and Pronouncements

Recently Issued Accounting Standards and Pronouncements

In August 2017, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2017-12 Targeted Improvements to Accounting for Hedging Activities. This update makes more financial and nonfinancial hedging strategies eligible for hedge accounting. It also amends the presentation and disclosure requirements and changes how companies assess effectiveness. This update will be effective for the Company for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted upon its issuance. The Company is currently assessing the impact of the future adoption of this standard on its financial statements.

In May 2017, the FASB issued ASU 2017-09, Compensation-Stock Compensation (Topic 718) Scope of Modification Accounting. ASU 2017-09 addresses the changes to the terms and conditions of share-based awards. ASU 2017-09 is effective for periods beginning after December 15, 2017 and interim periods therein on a modified retrospective basis. The Company adopted the new ASU as of January 1, 2018, and it did not have a material impact on the financial statements.

In January 2017, the FASB issued ASU 2017-04, Intangibles - Goodwill and Other, which simplifies the test for goodwill impairment. The guidance is effective for the Company beginning in the first quarter of fiscal year 2020. Early adoption is permitted for interim or annual goodwill impairments tests after January 1, 2017. This standard will impact future financial statements when adopted.

In February 2016, the FASB issued ASU 2016-02, Leases. The main objective of this update is to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. This ASU is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the impact ASU 2016-02 may have on its financial statements.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, which has been updated through several revisions and clarifications since its original issuance. The core principle of the new standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in accordance with the transfer of control over those goods and services. The new standard also requires additional disclosures intended to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue, and the related cash flows. The standard is effective for interim and annual reporting periods beginning after December 15, 2017. The Company adopted the new standard as of January 1, 2018, using the modified retrospective approach to all contracts that were not completed as of January 1, 2018. Prior period results were not adjusted and continue to be reported under the accounting standards in effect for the prior period. See the Revenue Recognition subsection above in this Note 2 for further details on the impact to the Company’s financial statements upon adoption and practical expedients elected.

XML

Basis of Presentation and Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2018

Accounting Policies [Abstract]

Schedule of Disaggregated Revenue

Revenues for the three months ended March 31, 2018 (in thousands)
Region	North America		EMEA		Latin America		Asia Pacific		Total Revenue
Product
1-MCP based	$	1,962	$	5,120	$	20,949	$	4,328	$	32,359
Fungicides, waxes, coatings, biocides	—		5,589		—		—		5,589
Other*	98		198		6		101		403
	$	2,060	$	10,907	$	20,955	$	4,429	$	38,351
Pattern of Revenue Recognition
Products transferred at a point in time	$	2,047	$	10,905	$	20,949	$	4,328	$	38,229
Services transferred over time	13		2		6		101		122
	$	2,060	$	10,907	$	20,955	$	4,429	$	38,351

*Other includes RipeLock, AdvanStore, technical services and sales type leases related to Tecnidex

Schedule of Changes in Contract Assets and Liabilities

The following table presents changes in the Company’s contract assets and liabilities during the three months ended March 31, 2018:

Three months ended March 31, 2018	Balance at January 1, 2018		Additions		Deductions			Balance at March 31, 2018
(in thousands)
Contract assets:
Unbilled revenue	$	739	$	4,268	$	(739	)	$	4,268
Contract liabilities:
Deferred revenue	$	100	$	880	$	—		$	980

Summary of Affect of ASC 606 on Financial Statements

The following table summarizes the amounts by which the consolidated financial statements are affected in the current reporting period by ASC 606 as compared with the guidance that was in effect before the change.

(in thousands)	As reported			ASC 606 Adjustments			Balances without adoption of ASC 606
Consolidated Balance Sheet
Liabilities
Accrued expenses and other current liabilities	$	43,391		$	(782	)	$	42,609
Equity
Accumulated deficit	$	(121,696	)	$	782		$	(120,914	)

(in thousands)	As reported			ASC 606 Adjustments		Balances without adoption of ASC 606
Consolidated Statements of Operations
Revenue
Net sales	$	38,351		$	782	$	39,133
Net loss attributable to AgroFresh Solutions, Inc	(12,967		)	$	610	$	(12,357	)

XML

Related Party Transactions (Tables)

3 Months Ended

Mar. 31, 2018

Related Party Transactions [Abstract]

Schedule of incurred expenses for services

The Company incurred expenses for such services for the three months ended March 31, 2018 and March 31, 2017 as follows:

(amounts in thousands)	Three Months Ended March 31, 2018		Three Months Ended March 31, 2017
Amortization of prepayment related to set-up of transition services	$	—	$	207
Ongoing costs of transition services agreement	84		743
Rent expense	—		248
Other expenses	295		95
Total incurred expenses	$	379	$	1,293

XML

Inventories (Tables)

3 Months Ended

Mar. 31, 2018

Inventory Disclosure [Abstract]

Schedule of inventories

Inventories at March 31, 2018 and December 31, 2017 consisted of the following:

(in thousands)	March 31, 2018		December 31, 2017
Raw material	$	1,967	$	2,148
Work-in-process	3,456		6,585
Finished goods	14,476		14,647
Supplies	713		729
Total inventories	$	20,612	$	24,109

XML

Other Current Assets (Tables)

3 Months Ended

Mar. 31, 2018

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of other current assets

The Company's other current assets at March 31, 2018 and December 31, 2017 consisted of the following:

(in thousands)	March 31, 2018		December 31, 2017
VAT receivable	$	14,454	$	14,088
Prepaid income tax asset	2,289		2,314
Other	5,097		2,282
Total other current assets	$	21,840	$	18,684

XML

Property and Equipment (Tables)

3 Months Ended

Mar. 31, 2018

Property, Plant and Equipment [Abstract]

Property and equipment

Property and equipment at March 31, 2018 and December 31, 2017 consisted of the following:

(in thousands, except for useful life data)	Useful life (years)	March 31, 2018			December 31, 2017
Leasehold improvements	7-20	$	3,015		$	2,976
Machinery & equipment	1-12	7,799			7,853
Furniture	1-12	1,707			1,698
Construction in progress		3,987			2,075
		16,508			14,602
Less: accumulated depreciation		(2,771		)	(2,402		)
Total property and equipment, net		$	13,737		$	12,200

XML

Goodwill and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of changes in the carrying amount of goodwill

Changes in the carrying amount of goodwill for the three months ended March 31, 2018 are as follows:

(in thousands)	Goodwill
Balance as of December 31, 2017	$	9,402
Measurement period adjustment	(3,654		)
Balance as of March 31, 2018	$	5,748

Schedule of other intangible assets

The Company’s intangible assets at March 31, 2018 and December 31, 2017 consisted of the following:

	March 31, 2018							December 31, 2017
(in thousands)	Gross Carrying Amount		Accumulated Amortization			Net		Gross Carrying Amount		Accumulated Amortization			Net
Other intangible assets:
Developed technology	$	759,374	$	(105,089	)	$	654,285	$	759,374	$	(94,886	)	$	664,488
In-process research and development	39,000		(3,431		)	35,569		39,000		(2,889		)	36,111
Trade name	29,816		—			29,816		29,816		—			29,816
Service provider network	2,000		—			2,000		2,000		—			2,000
Customer relationships	20,306		(889		)	19,417		20,306		(806		)	19,500
Software	1,274		(477		)	797		1,274		(404		)	870
Software not yet placed in service	5,022		—			5,022		5,022					5,022
Other	100		(29		)	71		100		(25		)	75
Total intangible assets	$	856,892	$	(109,915	)	$	746,977	$	856,892	$	(99,010	)	$	757,882

Schedule of estimated annual amortization expense for finite-lived intangible assets

Estimated annual amortization expense for finite-lived intangible assets, excluding amounts in Work in Progress, subsequent to March 31, 2018 is as follows:

(in thousands)	Amount
2018 (remaining)	$	32,753
2019	43,970
2020	43,951
2021	43,814
2022	43,691
Thereafter	501,960
Total	$	710,139

XML

Accrued and Other Current Liabilities (Tables)

3 Months Ended

Mar. 31, 2018

Payables and Accruals [Abstract]

Accrued and other current liabilities

The Company’s accrued and other current liabilities at March 31, 2018 and December 31, 2017 consisted of the following:

(in thousands)	March 31, 2018		December 31, 2017
Tax amortization benefit contingency	$	11,820	$	11,820
Additional consideration due seller	831		693
Dow settlement liability	—		10,000
Accrued compensation and benefits	7,252		8,932
Accrued rebates payable	5,045		5,027
Insurance premium financing payable	321		639
Severance	395		113
Deferred revenue	980		100
Other notes payable	1,401		5,056
Accrued taxes	8,710		7,848
Accrued interest	6,527		6,321
Other	109		9,260
Total accrued and other current liabilities	$	43,391	$	65,809

XML

Debt (Tables)

3 Months Ended

Mar. 31, 2018

Debt Disclosure [Abstract]

Schedule of debt, net of unamortized discount and deferred financing fees

The Company’s debt, net of unamortized discounts and deferred financing fees, at March 31, 2018 and December 31, 2017 consisted of the following:

(in thousands)	March 31, 2018		December 31, 2017
Total Term Loan outstanding	$	406,568	$	407,109
Tecnidex loan outstanding	3,341		3,685
Less: Amounts due within one year	7,700		7,926
Total long-term debt due after one year	$	402,209	$	402,868

Schedule of principal repayments under the term loan

Scheduled principal repayments of debt subsequent to March 31, 2018 are as follows:

(in thousands)	Amount
2018 (remaining)	$	6,637
2019	5,204
2020	4,250
2021	401,625
Total	$	417,716

XML

Other Noncurrent Liabilities (Tables)

3 Months Ended

Mar. 31, 2018

Liabilities, Other than Long-term Debt, Noncurrent [Abstract]

Other noncurrent liabilities

The Company’s other noncurrent liabilities at March 31, 2018 and December 31, 2017 consisted of the following:

(in thousands)	March 31, 2018		December 31, 2017
Tax amortization benefit contingency	$	32,670	$	31,562
Other	6,523		6,943
Total other noncurrent liabilities	$	39,193	$	38,505

XML

Stock-based Compensation (Tables)

3 Months Ended

Mar. 31, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Summary of share-based awards granted

Performance-based phantom shares	24,450
Service-based phantom shares	41,750
Stock appreciation rights	2,800
Total	69,000

Performance-based restricted stock units	195,650
Time-based restricted stock	149,700
Options	134,250
Total	479,600

Summary of valuation assumptions

Volatility	69.9		%
Risk-free interest rate	2.39		%
Dividend yield	0.00		%
Grant date stock price	$	7.35
Performance period	3 years

Volatility	48.80		%
Risk-free interest rate	2.56		%
Dividend yield	0.00		%
Grant date stock price	$	7.35
Expected term	6 years

XML

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2018

Earnings Per Share [Abstract]

Schedule of weighted average common shares outstanding

The following is a reconciliation of the weighted-average common shares outstanding used for the computation of basic and diluted net loss per common share:

	Three Months Ended March 31, 2018	Three Months Ended March 31, 2017
Basic weighted-average common shares outstanding	49,741,593	49,661,469
Effect of dilutive options, performance stock units and restricted stock	—	—
Dilute weighted-average shares outstanding	49,741,593	49,661,469

Amounts that could potentially dilute basic earnings per share

The following represents amounts that could potentially dilute basic earnings per share in the future:

(in thousands, except share data)	Three Months Ended March 31, 2018	Three Months Ended March 31, 2017
Stock-based compensation awards(1):
Stock options	63,019	926,898
Restricted stock to non-directors	610,642	797,401
Restricted stock to directors	122,929	78,754
Warrants:
Private placement warrants	6,160,000	6,160,000
Public warrants	9,823,072	9,823,072

———————————————————————————————

(1) SARs and Phantom Shares are payable in cash so will therefore have no impact on number of shares

XML

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2018

Fair Value Disclosures [Abstract]

Tabular disclosure of financial instruments measured at fair value on a recurring basis

The following table presents the fair value of the Company’s financial instrument liability/(asset) that are measured at fair value on a recurring basis as of March 31, 2018:

(in thousands)	Level 1		Level 2			Level 3		Total
Tax amortization benefit contingency(1)	$	—	$	—		$	44,490	$	44,490
Contingent consideration(2)	—		—			831		831
Interest rate contract (3)	—		(2,244		)	—		(2,244		)
Stock appreciation rights(4)	—		—			176		176
Phantom shares(5)	—		—			286		286
Total	$	—	$	(2,244	)	$	45,783	$	43,539

The following table presents the fair value of the Company’s financial instruments that are measured at fair value on a recurring basis as of December 31, 2017:

(in thousands)	Level 1		Level 2		Level 3		Total
Tax amortization benefit contingency(1)	$	—	$	—	$	43,382	$	43,382
Contingent consideration(2)	—		—		693		693
Interest rate contract (3)	—		456		—		456
Stock appreciation rights(4)	—		—		268		268
Phantom shares(5)	—		—		186		186
Total	$	—	$	456	$	44,529	$	44,985

———————————————————————————————

(1) The fair value of the tax amortization benefit contingency is measured using an income approach based on the Company’s best estimate of the undiscounted cash payments to be made, with the current portion tax effected at 35.3% and the non-current portion tax effected at 21.5% due to the Tax Cuts and Job Act (TCJA) of December 2017 enacted in the U.S and discounted to present value utilizing an appropriate market discount rate. Per the April 4, 2017 Amendment Agreement, payments due to Dow under the Tax Receivable Agreement was reduced from 85% to 50% of the applicable tax savings realized by the Company. The valuation technique used did not change during the three months ended March 31, 2018.

(2) The fair value of the contingent consideration related to the Tecnidex acquisition.

(3) The derivative assets and liabilities relate to an interest rate derivative that is measured at fair value using observable market inputs such as interest rates, our own credit risks as well as an evaluation of the counterparts' credit risks. The fair value for the three months ended March 31, 2018 resulted in an asset balance while the three months ended December 31, 2017 is in a liability balance.

(4) The fair value of the stock appreciation rights was measured using a Black Scholes pricing model during the three months ended March 31, 2018. The valuation technique used did not change during the three months ended March 31, 2018.

(5) The fair value of phantom shares are based on the fair value of the Company's common stock. The valuation technique used did not change during the three months ended March 31, 2018.

Changes in financial instruments measured at level 3 fair value on a recurring basis

The following table presents the changes during the period presented in our Level 3 financial instrument liability/(asset) that are measured at fair value on a recurring basis.

(in thousands)	Tax amortization benefit contingency		Contingent consideration related to acquisition		Interest rate contract			Stock appreciation rights			Phantom shares		Total
Balance, December 31, 2017	$	43,382	$	693	$	456		$	268		$	186	$	44,985
Accretion	1,108		—		—			—			—		1,108
Stock compensation expense	—		—		—			(92		)	100		8
Mark-to-market adjustment	—		138		(2,700		)	—			—		(2,562		)
Balance, March 31, 2018	$	44,490	$	831	$	(2,244	)	$	176		$	286	$	43,539

XML

Description of Business (Details) storage_room in Thousands	3 Months Ended
	Mar. 31, 2018 customer country storage_room
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of operating countries (over) | country	45
Number of customers | customer	3,700
Number of service locations | storage_room	25

XML

Basis of Presentation and Summary of Significant Accounting Policies - Summary of Disaggregation of Revenue (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2018 USD ($)
Disaggregation of Revenue [Line Items]
Total Revenue	$ 38,351
North America
Disaggregation of Revenue [Line Items]
Total Revenue	2,060
EMEA
Disaggregation of Revenue [Line Items]
Total Revenue	10,907
Latin America
Disaggregation of Revenue [Line Items]
Total Revenue	20,955
Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenue	4,429
Products transferred at a point in time
Disaggregation of Revenue [Line Items]
Total Revenue	38,229
Products transferred at a point in time | North America
Disaggregation of Revenue [Line Items]
Total Revenue	2,047
Products transferred at a point in time | EMEA
Disaggregation of Revenue [Line Items]
Total Revenue	10,905
Products transferred at a point in time | Latin America
Disaggregation of Revenue [Line Items]
Total Revenue	20,949
Products transferred at a point in time | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenue	4,328
Services transferred over time
Disaggregation of Revenue [Line Items]
Total Revenue	122
Services transferred over time | North America
Disaggregation of Revenue [Line Items]
Total Revenue	13
Services transferred over time | EMEA
Disaggregation of Revenue [Line Items]
Total Revenue	2
Services transferred over time | Latin America
Disaggregation of Revenue [Line Items]
Total Revenue	6
Services transferred over time | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenue	101
1-MCP based
Disaggregation of Revenue [Line Items]
Total Revenue	32,359
1-MCP based | North America
Disaggregation of Revenue [Line Items]
Total Revenue	1,962
1-MCP based | EMEA
Disaggregation of Revenue [Line Items]
Total Revenue	5,120
1-MCP based | Latin America
Disaggregation of Revenue [Line Items]
Total Revenue	20,949
1-MCP based | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenue	4,328
Fungicides, waxes, coatings, biocides
Disaggregation of Revenue [Line Items]
Total Revenue	5,589
Fungicides, waxes, coatings, biocides | North America
Disaggregation of Revenue [Line Items]
Total Revenue	0
Fungicides, waxes, coatings, biocides | EMEA
Disaggregation of Revenue [Line Items]
Total Revenue	5,589
Fungicides, waxes, coatings, biocides | Latin America
Disaggregation of Revenue [Line Items]
Total Revenue	0
Fungicides, waxes, coatings, biocides | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenue	0
Other
Disaggregation of Revenue [Line Items]
Total Revenue	403
Other | North America
Disaggregation of Revenue [Line Items]
Total Revenue	98
Other | EMEA
Disaggregation of Revenue [Line Items]
Total Revenue	198
Other | Latin America
Disaggregation of Revenue [Line Items]
Total Revenue	6
Other | Asia Pacific
Disaggregation of Revenue [Line Items]
Total Revenue	$ 101

XML

Basis of Presentation and Summary of Significant Accounting Policies - Summary of Contract Assets and Liabilities (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2018 USD ($)
Contract assets:
Balance at January 1, 2018	$ 739
Additions	4,268
Deductions	(739)
Balance at March 31, 2018	4,268
Contract liabilities:
Balance at January 1, 2018	100
Additions	880
Deductions	0
Balance at March 31, 2018	980
Reclassified from unbilled revenue to accounts receivable	700
Reclassified from deferred revenue to revenue	$ 0

XML

Basis of Presentation and Summary of Significant Accounting Policies - Summary of Modified Retrospective Approach (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Liabilities
Accrued expenses and other current liabilities	$ 43,391		$ 65,809
Equity
Accumulated deficit	(121,696)		$ (108,729)
Revenue
Net sales	38,351	$ 32,730
Net loss attributable to AgroFresh Solutions, Inc	(12,967)	$ (12,029)
Balances without adoption of ASC 606
Liabilities
Accrued expenses and other current liabilities	42,609
Equity
Accumulated deficit	(120,914)
Revenue
Net sales	39,133
Net loss attributable to AgroFresh Solutions, Inc	(12,357)
Accounting Standards Update 2014-09 | ASC 606 Adjustments
Liabilities
Accrued expenses and other current liabilities	(782)
Equity
Accumulated deficit	782
Revenue
Net sales	782
Net loss attributable to AgroFresh Solutions, Inc	$ 610

XML

Business Combinations (Details) - USD ($) $ in Thousands						3 Months Ended		7 Months Ended
	Jan. 31, 2018	Dec. 01, 2017	Apr. 04, 2017	Nov. 18, 2015	Jul. 31, 2015	Mar. 31, 2018	Mar. 31, 2017	Jun. 30, 2018
Class of Warrant or Right [Line Items]
Stock repurchase period				1 year
Increase (decrease) in fair value of contingent consideration						$ 138	$ 215
Dow
Class of Warrant or Right [Line Items]
Number of shares authorized to be repurchased (in shares)						5,070,358
Percentage of number of shares outstanding						10.00%
Stock repurchase period						18 months
Amendment agreement | Dow
Class of Warrant or Right [Line Items]
Increase (decrease) in liabilities			$ 20,000
Cash paid to related party	$ 10,000		10,000
Increase (decrease) in fair value of contingent consideration			(95,100)
Settlement of Dow liabilities, increase in deferred income taxes			40,000
Settlement of Dow liabilities			$ 55,100
Tax receivables agreement (TRA) | Dow
Class of Warrant or Right [Line Items]
Rate of tax receivable agreement			50.00%		85.00%
AgroFresh Inc.
Class of Warrant or Right [Line Items]
Cash consideration					$ 635,000
Tecnidex Fruit Protection, S.A.U.
Class of Warrant or Right [Line Items]
Cash consideration		$ 20,000
Percentage of voting interests acquired		75.00%
Tecnidex Fruit Protection, S.A.U. | Scenario, forecast
Class of Warrant or Right [Line Items]
Cash consideration								$ 25,000
Common Stock | AgroFresh Inc.
Class of Warrant or Right [Line Items]
Number of shares issued as consideration (in shares)					17,500,000
Level 3 | Tecnidex Fruit Protection, S.A.U.
Class of Warrant or Right [Line Items]
Contingent consideration		$ 700
Adjustment to purchase price allocation						$ 3,700

XML

Related Party Transactions (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Nov. 29, 2016
Director | Mutal services agreement
Related party transactions
Outstanding payable to related party	$ 0
Consulting fee, daily			$ 5
Expenses paid per service agreement	0
Dow | Seperate IT Services
Related party transactions
Payment amount for services	700
Dow | Dow
Related party transactions
Payment amount for services	379	$ 1,293
Outstanding payable to related party	0	300
Dow | Dow | Amortization of prepayment related to set-up of transition services
Related party transactions
Payment amount for services	0	207
Dow | Dow | Ongoing costs of the transition services agreement / Rent and Other
Related party transactions
Payment amount for services	84	743
Dow | Dow | Rent | Ongoing costs of the transition services agreement / Rent and Other
Related party transactions
Payment amount for services	0	248
Dow | Dow | Other Expense | Ongoing costs of the transition services agreement / Rent and Other
Related party transactions
Payment amount for services	$ 295	$ 95

XML

Inventories (Detail) - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Inventory Disclosure [Abstract]
Raw material	$ 1,967	$ 2,148
Work-in-process	3,456	6,585
Finished goods	14,476	14,647
Supplies	713	729
Total inventories	$ 20,612	$ 24,109

XML

Other Current Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
VAT receivable	$ 14,454	$ 14,088
Prepaid income tax asset	2,289	2,314
Other	5,097	2,282
Total other current assets	$ 21,840	$ 18,684

XML

Property and Equipment (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 16,508		$ 14,602
Less: accumulated depreciation	(2,771)		(2,402)
Property and equipment, net	13,737		12,200
Depreciation expense	400	$ 300
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 3,015		2,976
Leasehold improvements | Minimum
Property, Plant and Equipment [Line Items]
Useful life (in years)	7 years
Leasehold improvements | Maximum
Property, Plant and Equipment [Line Items]
Useful life (in years)	20 years
Machinery & equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 7,799		7,853
Machinery & equipment | Minimum
Property, Plant and Equipment [Line Items]
Useful life (in years)	1 year
Machinery & equipment | Maximum
Property, Plant and Equipment [Line Items]
Useful life (in years)	12 years
Furniture
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 1,707		1,698
Furniture | Minimum
Property, Plant and Equipment [Line Items]
Useful life (in years)	1 year
Furniture | Maximum
Property, Plant and Equipment [Line Items]
Useful life (in years)	12 years
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 3,987		$ 2,075

XML

Goodwill and Intangible Assets - Schedule of Goodwill (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2018 USD ($)
Goodwill [Roll Forward]
December 31, 2017	$ 9,402
Measurement period adjustment	(3,654)
March 31, 2018	$ 5,748

XML

Goodwill and Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Dec. 31, 2017
Other intangible assets:
Total intangible assets	$ 856,892	$ 856,892
Accumulated Amortization	(109,915)	(99,010)
Net, finite-lived intangible assets	710,139
Total intangible assets, net	$ 746,977	757,882
Weighted average
Other intangible assets:
Useful life	17 years 1 month 13 days
Trade name
Other intangible assets:
Gross carrying amount, indefinite-lived	$ 29,816	29,816
Service provider network
Other intangible assets:
Gross carrying amount, indefinite-lived	2,000	2,000
Software not yet placed in service
Other intangible assets:
Gross carrying amount, indefinite-lived	5,022	5,022
Developed technology
Other intangible assets:
Gross carrying amount, finite-lived	759,374	759,374
Accumulated Amortization	(105,089)	(94,886)
Net, finite-lived intangible assets	$ 654,285	664,488
Developed technology | Weighted average
Other intangible assets:
Useful life	17 years
In-process research and development
Other intangible assets:
Gross carrying amount, finite-lived	$ 39,000	39,000
Accumulated Amortization	(3,431)	(2,889)
Net, finite-lived intangible assets	$ 35,569	36,111
In-process research and development | Weighted average
Other intangible assets:
Useful life	16 years 6 months
Customer relationships
Other intangible assets:
Gross carrying amount, finite-lived	$ 20,306	20,306
Accumulated Amortization	(889)	(806)
Net, finite-lived intangible assets	$ 19,417	19,500
Customer relationships | Weighted average
Other intangible assets:
Useful life	21 years 3 months 18 days
Software
Other intangible assets:
Gross carrying amount, finite-lived	$ 1,274	1,274
Accumulated Amortization	(477)	(404)
Net, finite-lived intangible assets	$ 797	870
Software | Weighted average
Other intangible assets:
Useful life	2 years 7 months 6 days
Other
Other intangible assets:
Gross carrying amount, finite-lived	$ 100	100
Accumulated Amortization	(29)	(25)
Net, finite-lived intangible assets	$ 71	$ 75
Other | Weighted average
Other intangible assets:
Useful life	4 years 3 months 18 days

XML

Goodwill and Intangible Assets - Future Amortization (Details) $ in Thousands	Mar. 31, 2018 USD ($)
Estimated annual amortization expense
2018 (remaining)	$ 32,753
2019	43,970
2020	43,951
2021	43,814
2021	43,691
Thereafter	501,960
Net, finite-lived intangible assets	$ 710,139

XML

Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Payables and Accruals [Abstract]
Tax amortization benefit contingency	$ 11,820	$ 11,820
Additional consideration due seller	831	693
Dow settlement liability	0	10,000
Accrued compensation and benefits	7,252	8,932
Accrued rebates payable	5,045	5,027
Insurance premium financing payable	321	639
Severance	395	113
Deferred revenue	980	100
Other notes payable	1,401	5,056
Accrued taxes	8,710	7,848
Accrued interest	6,527	6,321
Other	109	9,260
Accrued and other current liabilities	$ 43,391	$ 65,809

XML

Debt (Details) - USD ($)		3 Months Ended		12 Months Ended
	Jul. 31, 2015	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2016	Nov. 18, 2015
Credit facility
Long term debt, gross		$ 417,716,000
Amortization of deferred financing costs		601,000	$ 579,000
Excess cash flows, repayment of debt, percentage				50.00%
Excess cash flows threshold for dividends				$ 5,000,000
Credit Facility
Credit facility
Maximum dividends paid and shares and warrants repurchased per fiscal year					$ 12,000,000
Aggregate purchase price of warrants					$ 10,000,000
Credit Facility | Alternate base rate
Credit facility
Margin of interest (as a percent)	3.75%
Credit Facility | LIBOR
Credit facility
Margin of interest (as a percent)	4.75%
Variable rate base minimum (as a percent)	1.00%
Term loan
Credit facility
Debt issuance costs incurred	$ 12,900,000
Deferred issuance costs, net		7,700,000
Face amount	$ 425,000,000
Amortization per year (as a percent)	1.00%
Long term debt, gross		414,300,000
Revolving loan
Credit facility
Debt issuance costs incurred	$ 1,300,000
Maximum borrowing available	25,000,000
Long term debt, gross		0
Letter-of-credit sub-facility
Credit facility
Maximum borrowing available	$ 10,000,000	525,000
Letters of credit, amount outstanding		0
Level 2 | Term loan
Credit facility
Fair value of debt		417,500,000
Prepayment due to Excess Cash Flow provision | Term loan
Credit facility
Repayments of principal in next 12 months		$ 0

XML

Debt - Net of Unamortized Discounts and Deferred Financing Fees (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Less: Amounts due within one year	$ 7,700	$ 7,926
Total long-term debt due after one year	402,209	402,868
Term loan
Debt Instrument [Line Items]
Total Term Loan outstanding	406,568	407,109
Loans Payable
Debt Instrument [Line Items]
Total Term Loan outstanding	$ 3,341	$ 3,685

XML

Debt - Principal Repayments (Details) $ in Thousands	Mar. 31, 2018 USD ($)
Schedule of principal repayments under the Term Loan
2018 (remaining)	$ 6,637
2019	5,204
2020	4,250
2021	401,625
Total	$ 417,716

XML

Other Noncurrent Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Liabilities, Other than Long-term Debt, Noncurrent [Abstract]
Tax amortization benefit contingency	$ 32,670	$ 31,562
Other	6,523	6,943
Total other noncurrent liabilities	$ 39,193	$ 38,505

XML

Severance (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Compensation Related Costs [Abstract]
Severance expense	$ 0.3	$ 0.0
Severance liability	0.5
Severance liability, current	$ 0.4

XML

Stockholders' Equity (Details)			3 Months Ended	12 Months Ended
	Nov. 18, 2015 USD ($)	Jul. 31, 2015 USD ($) $ / shares shares	Mar. 31, 2018 vote director $ / shares shares	Nov. 17, 2016 USD ($) shares	Dec. 31, 2015 shares	Dec. 31, 2017 $ / shares shares	Feb. 28, 2014 shares
Class of Warrant or Right [Line Items]
Authorized common stock (in shares)			400,000,000			400,000,000
Par value of common stock (in dollars per share) | $ / shares			$ 0.0001			$ 0.0001
Number of votes entitled by holders of common stock for each share of common stock | vote			1
Common stock, shares outstanding (in shares)			50,394,366			50,340,853
Number of shares issuable upon exercise of warrants (in shares)			15,983,072
Exercise price (in dollars per share) | $ / shares			$ 11.5
Number of warrants outstanding (in shares)			15,983,072
Shares authorized (in shares) | $	$ 10,000,000
Stock repurchase period	1 year
Shares repurchased during period (in shares)				661,381
Value of treasury stock acquired | $				$ 3,900,000
Rohm and Haas
Class of Warrant or Right [Line Items]
Number of shares of Series A Preferred Stock issued as condition to consummation of business combination (in shares)		1
Number of directors preferred stockholder is entitled to appoint if minimum ownership percentage of common stock is maintained | director			1
Minimum percentage of outstanding shares of voting and non-voting common stock to be held to entitle preferred stockholder to appoint director			10.00%
Public
Class of Warrant or Right [Line Items]
Number of warrants outstanding (in shares)							9,823,072
Number of warrants repurchased (in shares)					1,201,928
Private placement
Class of Warrant or Right [Line Items]
Number of warrants outstanding (in shares)							6,160,000
Shares issued during period (in shares)		4,878,048
Issue price of stock (in dollars per share) | $ / shares		$ 10.25
Value of shares issued during period | $		$ 50,000,000

XML

Stock-based Compensation (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-based compensation expense	$ 0.6	$ 0.2
Share-based compensation, nonvested awards, compensation cost not yet recognized	$ 3.5
Period for recognition of compensation on unvested stock option	1 year 8 months 27 days

XML

Stock-based Compensation - Schedule of Shares Granted (Details)	Mar. 31, 2018 shares
United States
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted (in shares)	134,250
Equity awards granted (in shares)	479,600
United States | Performance-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock units granted (in shares)	195,650
United States | Time-based restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock units granted (in shares)	149,700
Outside the United States
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock appreciation rights granted (in shares)	2,800
Equity awards granted (in shares)	69,000
Outside the United States | Performance-based phantom shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock units granted (in shares)	24,450
Outside the United States | Service-based phantom shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock units granted (in shares)	41,750

XML

Stock-based Compensation - Schedule of Assumptions (Details)	Mar. 31, 2018 $ / shares
Performance-based Restricted Stock Units and Phantom Shares
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Weighted average grant date fair value of share units (in dollars per share)	$ 7.28
Volatility	69.90%
Risk-free interest rate	2.39%
Dividend yield	0.00%
Grant date stock price (in dollars per share)	$ 7.35
Expected term	3 years
Stock Options And Stock Appreciation Rights
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Weighted average exercise price for options (in dollars per share)	$ 3.57
Volatility	48.80%
Risk-free interest rate	2.56%
Dividend yield	0.00%
Grant date stock price (in dollars per share)	$ 7.35
Expected term	6 years

XML

Earnings Per Share - Schedule of Weighted Average Common Shares Outstanding (Details) - shares	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Earnings Per Share [Abstract]
Basic weighted-average common shares outstanding (in shares)	49,741,593	49,661,469
Effect of dilutive options, performance stock units and restricted stock (in shares)	0	0
Dilute weighted-average shares outstanding (in shares)	49,741,593	49,661,469

XML

Earnings Per Share (Details) - shares		3 Months Ended
		Mar. 31, 2018	Mar. 31, 2017
Stock options
Earnings Per Share [Line Items]
Antidilutive securities (in shares)	[1]	63,019	926,898
Restricted Stock Units (RSUs)
Earnings Per Share [Line Items]
Antidilutive securities (in shares)	[1]	610,642	797,401
Warrants | Private placement
Earnings Per Share [Line Items]
Antidilutive securities (in shares)		6,160,000	6,160,000
Warrants | Public
Earnings Per Share [Line Items]
Antidilutive securities (in shares)		9,823,072	9,823,072
Director | Restricted Stock
Earnings Per Share [Line Items]
Antidilutive securities (in shares)	[1]	122,929	78,754

[1] SARs and Phantom Shares are payable in cash so will therefore have no impact on number of shares

XML

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Income Tax Contingency [Line Items]
Provisional tax expense			$ 0.5
Provisional tax liability	$ 0.3
Effective tax rate (as a percent)	(38.40%)	(13.00%)
Statutory tax rate	21.00%

XML

Fair Value Measurements - Financial Instruments Measured on a Recurring Basis (Details) - USD ($)				3 Months Ended
		Apr. 04, 2017	Jul. 31, 2015	Mar. 31, 2018	Dec. 31, 2017
Recurring
Financial instruments measured at fair value on a recurring basis
Level 1 to level 2 transfers				$ 0
Transfers				0
Contingent consideration | Recurring
Financial instruments measured at fair value on a recurring basis
Total				43,539,000	$ 44,985,000
Contingent consideration | Recurring | Stock appreciation rights
Financial instruments measured at fair value on a recurring basis
Total	[1]			176,000	268,000
Contingent consideration | Recurring | Phantom shares
Financial instruments measured at fair value on a recurring basis
Total	[2]			286,000	186,000
Contingent consideration | Recurring | Level 1
Financial instruments measured at fair value on a recurring basis
Total				0	0
Contingent consideration | Recurring | Level 1 | Stock appreciation rights
Financial instruments measured at fair value on a recurring basis
Total	[1]			0	0
Contingent consideration | Recurring | Level 1 | Phantom shares
Financial instruments measured at fair value on a recurring basis
Total	[2]			0	0
Contingent consideration | Recurring | Level 2
Financial instruments measured at fair value on a recurring basis
Total				(2,244,000)	456,000
Contingent consideration | Recurring | Level 2 | Stock appreciation rights
Financial instruments measured at fair value on a recurring basis
Total	[1]			0	0
Contingent consideration | Recurring | Level 2 | Phantom shares
Financial instruments measured at fair value on a recurring basis
Total	[2]			0	0
Contingent consideration | Recurring | Level 3
Financial instruments measured at fair value on a recurring basis
Total				45,783,000	44,529,000
Contingent consideration | Recurring | Level 3 | Stock appreciation rights
Financial instruments measured at fair value on a recurring basis
Total	[1]			176,000	268,000
Contingent consideration | Recurring | Level 3 | Phantom shares
Financial instruments measured at fair value on a recurring basis
Total	[2]			286,000	186,000
Contingent consideration | AgroFresh Inc. | Recurring | Tax amortization benefit contingency
Financial instruments measured at fair value on a recurring basis
Total	[3]			44,490,000	43,382,000
Contingent consideration | AgroFresh Inc. | Recurring | Contingent consideration related to acquisition
Financial instruments measured at fair value on a recurring basis
Total	[4]			831,000	693,000
Contingent consideration | AgroFresh Inc. | Recurring | Interest rate contract
Financial instruments measured at fair value on a recurring basis
Total	[5]			(2,244,000)	456,000
Contingent consideration | AgroFresh Inc. | Recurring | Level 1 | Tax amortization benefit contingency
Financial instruments measured at fair value on a recurring basis
Total	[3]			0	0
Contingent consideration | AgroFresh Inc. | Recurring | Level 1 | Contingent consideration related to acquisition
Financial instruments measured at fair value on a recurring basis
Total	[4]			0	0
Contingent consideration | AgroFresh Inc. | Recurring | Level 1 | Interest rate contract
Financial instruments measured at fair value on a recurring basis
Total	[5]			0	0
Contingent consideration | AgroFresh Inc. | Recurring | Level 2 | Tax amortization benefit contingency
Financial instruments measured at fair value on a recurring basis
Total	[3]			0	0
Contingent consideration | AgroFresh Inc. | Recurring | Level 2 | Contingent consideration related to acquisition
Financial instruments measured at fair value on a recurring basis
Total	[4]			0	0
Contingent consideration | AgroFresh Inc. | Recurring | Level 2 | Interest rate contract
Financial instruments measured at fair value on a recurring basis
Total	[5]			(2,244,000)	456,000
Contingent consideration | AgroFresh Inc. | Recurring | Level 3 | Tax amortization benefit contingency
Financial instruments measured at fair value on a recurring basis
Total	[3]			$ 44,490,000	43,382,000
Tax effect rate				35.30%
Non-current portion new tax rate effect				21.50%
Contingent consideration | AgroFresh Inc. | Recurring | Level 3 | Contingent consideration related to acquisition
Financial instruments measured at fair value on a recurring basis
Total	[4]			$ 831,000	693,000
Contingent consideration | AgroFresh Inc. | Recurring | Level 3 | Interest rate contract
Financial instruments measured at fair value on a recurring basis
Total	[5]			$ 0	$ 0
Dow | Tax receivables agreement (TRA)
Financial instruments measured at fair value on a recurring basis
Percentage of tax savings to be paid		50.00%	85.00%

[1] The fair value of the stock appreciation rights was measured using a Black Scholes pricing model during the three months ended March 31, 2018. The valuation technique used did not change during the three months ended March 31, 2018.

[2] The fair value of phantom shares are based on the fair value of the Company's common stock. The valuation technique used did not change during the three months ended March 31, 2018.

[3] The fair value of the tax amortization benefit contingency is measured using an income approach based on the Company’s best estimate of the undiscounted cash payments to be made, with the current portion tax effected at 35.3% and the non-current portion tax effected at 21.5% due to the Tax Cuts and Job Act (TCJA) of December 2017 enacted in the U.S and discounted to present value utilizing an appropriate market discount rate. Per the April 4, 2017 Amendment Agreement, payments due to Dow under the Tax Receivable Agreement was reduced from 85% to 50% of the applicable tax savings realized by the Company. The valuation technique used did not change during the three months ended March 31, 2018.

[4] The fair value of the contingent consideration related to the Tecnidex acquisition.

[5] The derivative assets and liabilities relate to an interest rate derivative that is measured at fair value using observable market inputs such as interest rates, our own credit risks as well as an evaluation of the counterparts' credit risks. The fair value for the three months ended March 31, 2018 resulted in an asset balance while the three months ended December 31, 2017 is in a liability balance.

XML

Fair Value Measurements - Changes of Level 3 Financial Instruments (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2018 USD ($)
Contingent consideration
Financial instruments measured at Level 3 fair value on a recurring basis rollforward
Balance, beginning period	$ 44,985
Accretion	1,108
Stock compensation expense	8
Mark-to-market adjustment	(2,562)
Balance, ending period	43,539
Contingent consideration | Tax amortization benefit contingency
Financial instruments measured at Level 3 fair value on a recurring basis rollforward
Balance, beginning period	43,382
Accretion	1,108
Stock compensation expense	0
Mark-to-market adjustment	0
Balance, ending period	44,490
Contingent consideration | Contingent consideration related to acquisition
Financial instruments measured at Level 3 fair value on a recurring basis rollforward
Balance, beginning period	693
Accretion	0
Stock compensation expense	0
Mark-to-market adjustment	138
Balance, ending period	831
Contingent consideration | Interest rate contract
Financial instruments measured at Level 3 fair value on a recurring basis rollforward
Balance, beginning period	456
Accretion	0
Stock compensation expense	0
Mark-to-market adjustment	(2,700)
Balance, ending period	(2,244)
Contingent consideration | Stock appreciation rights
Financial instruments measured at Level 3 fair value on a recurring basis rollforward
Balance, beginning period	268
Accretion	0
Stock compensation expense	(92)
Mark-to-market adjustment	0
Balance, ending period	176
Contingent consideration | Phantom shares
Financial instruments measured at Level 3 fair value on a recurring basis rollforward
Balance, beginning period	186
Accretion	0
Stock compensation expense	100
Mark-to-market adjustment	0
Balance, ending period	286
Term loan | Level 2
Financial instruments measured at Level 3 fair value on a recurring basis
Fair value of debt	$ 417,500